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Deformability is an essential feature of blood cells (RBCs) that enables them to travel
through even the smallest capillaries of the human body. Deformability is a function of
(i) structural elements of cytoskeletal proteins, (ii) processes controlling intracellular ion
and water handling and (iii) membrane surface-to-volume ratio. All these factors may
be altered in various forms of hereditary hemolytic anemia, such as sickle cell disease,
thalassemia, hereditary spherocytosis and hereditary xerocytosis. Although mutations
are known as the primary causes of these congenital anemias, little is known about
the resulting secondary processes that affect RBC deformability (such as secondary
changes in RBC hydration, membrane protein phosphorylation, and RBC vesiculation).
These secondary processes could, however, play an important role in the premature
removal of the aberrant RBCs by the spleen. Altered RBC deformability could contribute
to disease pathophysiology in various disorders of the RBC. Here we review the current
knowledge on RBC deformability in different forms of hereditary hemolytic anemia and
describe secondary mechanisms involved in RBC deformability.
Keywords: deformability, vesiculation, sickle cell anemia, thalassemia, hereditary spherocytosis, enzymopathies,
hydration, hemolysis
INTRODUCTION
The primary function of RBCs is to enable respiration in tissues by providing oxygen and removing
carbon dioxide via gas exchange in the lungs. During a typical 120 days lifespan of a RBC, it
circulates through arteries, veins and small capillaries traveling –in total– a distance of 500 km
(Lasch et al., 2000). RBC deformability, i.e., the ability of the RBC to change shape is essential for
successful passage through these capillaries and splenic sinuses (Danielczok et al., 2017).
Deformability of RBC depends on the (i) structural properties of the “horizontal” cytoskeletal
components such as spectrin (Burton and Bruce, 2011; Nans et al., 2011), (ii) vertical interaction of
Abbreviations: 5-FU, 5-fluorouracil; AC, adenyl cyclase; AMPK, AMP-activated protein kinase; ATP, adenosine
triphosphate; Ca2+, calcium; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; Cl−,
chloride; DNA, deoxyribonucleic acid; ET-1, endothelin-1; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HbS,
hemoglobin S; HK, hexokinase; HS, hereditary spherocytosis; IL-10, interleukine-10; K+, potassium; KCC = K+-Cl−
cotransporter; KCNN4, calcium-activated potassium channel or Gardos channel; MCHC, mean corpuscular hemoglobin
concentration; Mg2+, magnesium; Na+, sodium; PAF, platelet-activating factor; PDE, phosphodiesterase; PK, pyruvate
kinase; PKA, protein kinase A; PKCα, protein kinase C alpha; PS, phosphatidylserine; RBCs, red blood cells; RNA, ribonucleic
acid.
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cytoskeleton and integral transmembrane complexes that is
accomplished by ankyrin, 4.1 and 4.2 protein and the cytosolic
domain of band 3 protein (also known as the anion exchanger 1
(AE1) or solute carrier family 4 member 1 (SLC4A1)) (Gallagher,
2004a) and (iii) resistance of the cytosolic pool (i.e., intracellular
viscosity, RBC hydration state and surface-volume interaction)
(Clark et al., 1983).
Deformability is also affected by metabolic processes
controlling ATP levels and redox state. These factors control
ion handling by pumps and passive transport pathways (Chu
et al., 2012; Bogdanova et al., 2016), proteolytic activity of
Ca2+-dependent protease calpain (Bogdanova et al., 2013),
and mutations and structural integrity of each element of the
membrane architecture (Gallagher, 2004b). Failure to sustain
deformability results in shortening of RBC life span and, when
not compensated by de novo RBC production, in hemolytic
anemia.
Therefore, reliable estimation of RBC deformability and
understanding of the processes in control of it are essential
for evaluation of severity of patients’ state and choosing of
the optimal therapeutic strategy. This particularly relates to the
feasibility of splenectomy as an option to improve or worsen
condition of patients with anemic state (Iolascon et al., 2017).
In this review, we provide an overview of the current
knowledge on the primary and secondary mechanisms involved
in regulation of RBC deformability in hereditary hemolytic
anemia. We discuss methodologies that are currently used
to assess RBC deformability in the clinical and research
laboratories. We link different processes, such as ion channel
activity, intracellular energy metabolism and phosphorylation
of membrane proteins to RBC deformability and illustrate how
these processes are affected in various RBC pathologies, such
as sickle cell disease, thalassemia, HS and metabolic defects of
RBCs. Finally, we describe the influence of shedding of nano-
sized membrane vesicles from the RBC, the oxygenation state
of hemoglobin and adaptive responses (such as exercise and
high-altitude) on RBC deformability. Increased shedding of RBC
vesicles, for example, is a feature of various RBC pathologies and
vesicles are increasingly being considered to be a novel biomarker
of RBC disorders (Pattanapanyasat et al., 2004; Nantakomol et al.,
2012; Alaarg et al., 2013). They are considered to be involved in
thrombosis and hemostasis (Biro et al., 2003; Livaja Koshiar et al.,
2014) and associated with reduced RBC deformability (Waugh
et al., 1992; Bosch et al., 1994).
RBC DEFORMABILITY IN HEREDITARY
HEMOLYTIC ANEMIA
Anemia is considered to be hemolytic when RBCs are
prematurely cleared from the circulation. Hemolytic anemia can
be further subdivided into intra- or extravascular hemolytic
anemia, and the underlying cause can be either inherited or
acquired. Intravascular hemolysis is, as the name suggests, lysis
of RBC in the vasculature. The cause can be hereditary, as seen
in sickle cell disease (Pauling and Itano, 1949; Kato et al., 2017),
but intravascular hemolysis can also be initiated by certain drugs
(Cappellini and Fiorelli, 2008), by mechanical stress (for example
through shear forces generated by artificial heart valves), by cold-
agglutination (Körmöczi et al., 2006) or as a result of exhaustive
exercise (Jordan et al., 1998). Intravascular hemolysis causes
the release of hemoglobin into the plasma. Free hemoglobin is
toxic and can lead to various clinical manifestations, such as
hemoglobinuria, renal dysfunction, pulmonary hypertension and
platelet activation (Rother et al., 2005).
Extravascular hemolysis is directly related to reduced RBC
deformability. RBCs with reduced deformability fail to pass the
spleen, which acts as an RBC quality-control organ (Mebius
and Kraal, 2005; Deplaine et al., 2010). The red pulp of the
spleen contains narrow inter-endothelial slits (MacDonald et al.,
1987). Failure to pass through these narrow slits (Mebius and
Kraal, 2005) leads to the uptake and breakdown of RBCs by
macrophages (Burger et al., 2012). A number of hereditary
RBC disorders result in reduced RBC deformability, which,
as a consequence, leads to premature removal of RBCs in
the spleen. Removal of RBCs by the spleen is, however, not
only dependent on reduced deformability, but also occurs after
recognition by macrophages. Senescent RBCs can be recognized
and phagocytized by macrophages in the spleen upon binding
of autologous antibodies to band 3 (Kay et al., 1983; Kay, 1984),
exposure of conformational altered CD47 (Burger et al., 2012) or
exposure of PS (Boas et al., 1998).
Hereditary forms of hemolytic anemia can affect the RBC
membrane (i.e., HS, elliptocytosis, and pyropoikilocytosis)
(Gallagher, 2004a; Perrotta et al., 2008; Da Costa et al., 2013),
its metabolism (i.e., enzymopathies) (Zanella and Bianchi,
2000; van Wijk and van Solinge, 2005; Koralkova et al.,
2014), cell hemoglobin (i.e., sickle cell anemia, unstable
hemoglobin variants) (Higgs et al., 2012; Ware et al., 2017),
or cellular hydration (i.e., HS, hereditary xerocytosis or Gardos
Channelopathy) (Vives Corrons and Besson, 2001; Albuisson
et al., 2013; Andolfo et al., 2013, 2015; Beneteau et al., 2014;
Faucherre et al., 2014; Glogowska et al., 2015; Fermo et al., 2017a).
While the primary genetic causes of these disorders are often well
determined, less is known about the factors triggering the actual
hemolysis. Striking examples are sickle cell disease, thalassemia,
HS and the metabolic disorders of the RBC. All have well-
known and well-studied primary genetic and molecular defects.
However, little is known about the secondary mechanisms that
may decrease RBC deformability and thereby contribute to the
premature removal of these affected RBCs.
For example, the homozygous single point mutation in the
HBB gene, substituting glutamic acid for valine at position 6 leads
to sickle cell disease (Ware et al., 2017). Although the discovery
that these RBCs tend to sickle at low oxygen tension was already
provided by Hahn and Gillespie (1927), Kenney et al. (1961), it
took decades to unravel the processes that contribute to sickle
cell dehydration (Lew and Bookchin, 2005; Ataga et al., 2008),
decreased deformability and increased endothelial cell adhesion
(Alapan et al., 2015, 2016). We still do not understand how
does a point mutation in hemoglobin beta chain cause these
secondary pathological alterations in density and adhesiveness
and how all these changes in turn impact the disease symptoms
of the patient. Other examples are the enzymopathies, which are
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FIGURE 1 | Osmotic gradient ektacytometry as a tool to measure red blood cell (RBC) deformability. The technique is discussed in detail by Clark et al. (1983);
Lazarova et al. (2017), and Da Costa et al. (2016). Briefly, during osmotic gradient ektacytometry, the RBC is subjected to an osmotic gradient (range
≈50 mOsmol/kg H2O – 650 mOsmol/kg H2O) under constant shear stress, while the elongation index (EI) is measured. The EI corresponds to the deformability at
various osmotic conditions. (A) the left graph depicts an osmotic gradient ektacytometry curve from a healthy control with various intersection points: the EImax
reflects the maximal deformability of the RBC, Omin reflects the osmotic fragility and Ohyper reflects the (de)hydration state (or intracellular viscosity) of the RBC. (B) In
the right graph osmotic gradient curves of patients with sickle cell disease (black line), β-thalassemia (green line), hereditary xerocytosis (blue line) and hereditary
spherocytosis (red line) and several individual healthy controls (gray lines, n = 20) are depicted.
caused by mutations in, for example, PK or HK and lead to a
shortage of metabolic energy inside the RBC. Again, although
the primary effect on decreased levels of ATP in these diseases is
well understood (Zanella et al., 2007), secondary processes such
as altered K+ fluxes (Nathan et al., 1965) and phosphorylation of
intracellular proteins (Thali et al., 2010; Wang et al., 2010), need
further elucidation.
Moreover, for a substantial number of patients with hereditary
hemolytic anemia – the primary causes of disease remain
unknown, or were only identified very recently. For these
patients, a comprehensive understanding of both primary and
secondary defects of the affected RBCs is still lacking. This is
illustrated by the recently discovered mutations in patients with
hereditary xerocytosis, also known as dehydrated stomatocytosis
(Andolfo et al., 2013). In these patients, stomatocytes are
typically found in peripheral blood smears. However, the primary
molecular cause for the anemia and morphological change
of the RBC remained unknown for a long time, let alone
that the secondary processes that are involved in the disease
process were elucidated. Only recently, it was shown that
hereditary xerocytosis was caused by mutations in genes for
the mechanosensitive PIEZO1 channel (Andolfo et al., 2013;
Shmukler et al., 2014; Glogowska et al., 2017). Very recently, a
mutation in the calcium-activated potassium channel subfamily
N member KCNN4 (encoded by the human KCa3.1 gene, and
also known as the Gardos channel in RBCs) (Andolfo et al.,
2015; Glogowska et al., 2015; Rapetti-Mauss et al., 2015; Fermo
et al., 2017a) was shown to cause ‘Gardos channelopathy’ a
disease resembling yet at some points different from hereditary
xerocytosis (Fermo et al., 2017a). Only then, the molecular
diagnosis of these diseases was established in these patient
groups and new insight on RBC deformability and RBC
ion homeostasis with respect to ion channel function were
obtained. The secondary processes that contribute to RBC
clearance in these diseases are now being explored (Fermo et al.,
2017a).
TECHNIQUES TO DETERMINE RBC
DEFORMABILITY
A currently well-established tool to probe RBC deformability
is osmotic gradient ektacytometry, which is routinely used in
the diagnosis of patients with hereditary hemolytic anemia. The
technique is performed on a Laser-assisted Optical Rotational
Cell Analyzer (Lorrca). It assesses RBC deformability, osmotic
fragility and cellular hydration status (see Figure 1) (Clark
et al., 1983; Da Costa et al., 2016; Lazarova et al., 2017;
Llaudet-Planas et al., 2017). In osmotic gradient ektacytometry,
the maximum RBC deformability is represented by the
maximum elongation index (EImax). The Omin represents
the osmotic value (mOsmol/kg H2O) where the elongation
index (EI) is minimal, corresponding to the 50% lysis
point as determined by the classical osmotical fragility test
(Clark et al., 1983). The hydration status (or intracellular
viscosity) is represented by Ohyper (mOsmol/kg H2O). The
value corresponds with the hypertonic osmolarity where the
EI is 50% of EImax. The value of these three parameters as
well as the shape of the curve is used in the diagnosis of
various disorders of the RBC membrane and hydration station
(Figure 1B).
Ohyper correlates with the reciprocal function of the MCHC
(Clark et al., 1983). In healthy individuals, during RBC aging
increased MCHC is observed and this correlates with decreased
RBC deformability (Clark et al., 1983; Bosch et al., 1994).
A similar observation has been made for RBCs from patients with
sickle cell disease and HS. Also here, a decrease in RBC hydration
(i.e., decreased Ohyper and increased MCHC) of patient’s cells is
associated with a decrease in the maximum RBC deformability
(EImax) (Clark et al., 1983; Bunn, 1997).
Besides osmotic gradient ektacytometry, there are other
methods to measure RBC deformability (Tomaiuolo, 2014).
A number of techniques that are also used in diagnostics
measures RBC deformability as a function of shear stress,
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for example the RheoScan-D (Shin et al., 2007), Automated
Rheoscope and Cell Analyser (ARCA) (Dobbe et al., 2002)
and the deformability measurement module on the Lorrca
(Hardeman et al., 1987). The results of RheoScan-D and the
deformability measurements (shear-stress module) on the Lorrca
were observed to be comparable (Shin et al., 2007). However,
RheoScan-D measures RBC deformability under microfluidic
conditions after the application of shear stress, while shear-
stress on RBCs in the deformability measurements on the Lorrca
requires a larger set-up with a rotating cup (Hardeman et al.,
1987; Shin et al., 2007). The ARCA measures RBC deformability
with a microscope after the application of shear-stress, and
therefore has the potential to measure the RBC deformability of
subpopulations (Dobbe et al., 2002).
Most direct measurements of single cells include: micropipette
(Waugh et al., 1992), atomic force spectroscopy and holographic
optical tweezers (HOT) (Steffen et al., 2011; Kaestner et al.,
2012). The mechanical probes and the optical approach are
complementary since 30 pN is a lower force limit for the
mechanical measurements and an upper limit for the HOT in
the context of investigating RBCs (Minetti et al., 2013). Currently
microfluidic approaches becoming increasingly popular to
investigate RBC deformability (Cluitmans et al., 2014; Guo et al.,
2014; Picot et al., 2015; Danielczok et al., 2017). While the latter
method has the potential to become a routine diagnostic tool, the
former single cell methods are mostly dedicated to basic research
due to their instrumental complexity.
A further very simple method to measure RBC deformability is
the readout of RBC filterability, e.g., by measuring RBC passage
through cellulose columns (Oonishi et al., 1997). Unfortunately
there is currently no standardized column/readout system
on the market that would allow comparison of filterability
between diagnostic laboratories. In addition, RBC passage
through cellulose columns or filters is highly subjected to
changes in cellular volume (such as MCV), which may affect
results. A summary of available techniques to measure RBC
deformability is depicted in Table 1.
DETERMINANTS OF RBC
DEFORMABILITY
RBC Hydration
Regulation of RBC Hydration
Red blood cell deformability is highly influenced by RBC
volume control and by ion content, both regulated by ion
pumps, ion channels, symporters and antiporters (Gallagher,
2013) (see Figure 2). When ion channels are open, ions move
following their electrochemical gradients, while ion pumps can
actively move these ions against the gradient (Gadsby, 2009).
Symporters and antiporters may also create secondary ion
gradients, but require the pre-existing gradients for at least
one type of ions as a driving force to transport the other ion
types against the gradient. Symporters transport two (e.g., K+-
Cl− cotransporter) or more (e.g., Na+-K+-2Cl− cotransporter)
ions in the same direction using driving force for one of
them, while antiporters (e.g., Na+/H+ exchanger or anion
exchanger) exchange two ions that move in the opposite direction
(Wolfersberger, 1994). These transporters, pumps and channels
are crucial in resisting/adapting to local osmotic changes and
maintaining RBC volume (Wieth, 1979; Liu et al., 2011; Thomas
et al., 2011; Gallagher, 2013; Lew and Tiffert, 2017). RBC volume
changes result from differences in osmotic pressure (Sugie et al.,
2018), which results in water transport by aquaporins of which
AQP1 and AQP3 are found in human RBCs (Yang et al., 2001).
Cotransport of water is, however, also possible through the K+-
Cl− cotransporter (KCC) (Zeuthen and Macaulay, 2012). Volume
changes are also associated by in- and eﬄux of several amino
acids and amino-acid derivates, such as taurine (Goldstein and
Brill, 1991; Goldstein and Davis, 1994).
As mentioned previously, MCHC is a parameter that reflects
the RBC hydration state, and is dependent on the hemoglobin
concentration in RBCs, RBC volume, RBC membrane loss and
water content. Quick movements of ions and water result in
acute changes in MCHC whereas long-term effects on MCHC are
often associated with release of hemoglobin-free vesicles. RBC
hydration may be quantified using the Ohyper value as obtained
by osmotic gradient ektacytometry (see Figure 1 and see section
“Techniques to Determine RBC Deformability”). Changes in
RBC density detected using cell distribution within Percoll
density gradients reflects both membrane loss and the changes
in RBC surface-to-volume ratio and alterations in intracellular
ion and water content. In-depth morphological analysis could
be used as a complementary approach to discriminate between
membrane and ion/water loss.
Primary Changes of RBC Hydration
In this section we shall address hereditary hemolytic anemias
associated with the changes in the intracellular ion and secondary
to the latter changes in water content. One of the players in this
type of disorder is a mechano-sensitive PIEZO1 channel, a non-
selective cation channel permeable for Ca2+ that in turn can
activate the calcium activated K+ channel subfamily N member
KCNN4 (or Gardos channel in RBCs) (Kaestner et al., 2018).
Thus, hydration state is largely dependent on the shear stress
intensity and the hydration state of RBCs from splenectomized
and non-splenectomized patients with the same mutation may
vary substantially. Furthermore, hydration state is a function of
RBC age, young RBCs being more hydrated than the senescent
cells (Clark et al., 1983; Lutz et al., 1992).
A RBC disorder characterized by primary hydration changes
is hereditary xerocytosis (HX), also known as dehydrated
stomatocytosis. HX is a form of hereditary hemolytic anemia,
and patients often suffer from iron-overload (Zarychanski et al.,
2012). In addition, in many RBC disorders splenectomy relieves
symptoms and increases RBC survival, but in HX, splenectomy
is contra-indicated as it drastically increases the risks for
thrombotic events (Stewart et al., 1996; Jaïs et al., 2003; Iolascon
et al., 2017). HX was related to mutations in the mechanosensitive
PIEZO1 channel (Zarychanski et al., 2012; Albuisson et al., 2013;
Li et al., 2014). PIEZO1 mutations lead to stabilization of the
“active” state or destabilization of the “inactive” state of the
PIEZO1 protein (Albuisson et al., 2013). These alterations in
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TABLE 1 | Overview of techniques to measure RBC deformability.
Method Principle Readouts Advantages Disadvantages/sources of
mistake
Osmotic fragility test
(OFT) (Parpart et al.,
1947)
The OFT tests RBC lysis at
various osmotic conditions.
Lysis in OFT depends on critical
RBC volume needed for
hemoglobin content.
50% lysis point Relatively easy
technique
Requires pre-incubation at 37◦C
and heparin blood, measurement of
population average. pH and
temperature of solutions can affect
results. Low sensitivity (Bianchi
et al., 2012).
Osmotic gradient
ektacytometry
(Clark et al., 1983; Da
Costa et al., 2016;
Lazarova et al., 2017)
RBC deformability is constantly
measured under constant
shear stress while osmotic
gradient gradually increases
from hypotonic to hypertonic
conditions.
Maximum deformability
(EImax), RBC hydration
(Ohyper) and 50% lysis
point in OFT (Omin)
Robust and
reproducible,
diagnostic technique,
enables comparison
between laboratories
Measures RBC population average
Shear-stress
dependent
deformability
(Hardeman et al., 1987;
Dobbe et al., 2002;
Shin et al., 2007)
Measurement of RBC
deformability after application of
constant or increasing levels
stress-stress (i.e., Automated
Rheoscope and Cell Analyser
(ARCA), RheoScan-D, or
deformability on Lorrca).
Elongation index (EI)
and maximum
deformability EImax
Easy, reproducible and
diagnostic techniques
Automated Rheoscope
and Cell Analyser
(ARCA) can measure
deformability of
subpopulations
RheoScan-D and deformability
measurements on Lorrca measures
populations average. Automated
Rheoscope and Cell Analyser
(ARCA) requires a microscope,
which leads to number of cells that
are out of focus and are rejected
from analysis
Atomic force
microscopy (AFM)
(Yeow et al., 2017)
Scanning technique that uses a
tip as a probe to detect
morphological changes and
changes in deformability.
Measures the resistance after
application of force.
Elasticity, force,
resistance
Single cell technique
and AFM can measure
RBC deformability at
different spots per
RBC. Topographic
images can be
obtained.
Advanced equipment needed and
labor extensive, no gold standard
Micropipette (Waugh
et al., 1992)
Aspiration of cells or membrane
parts.
Surface area, volume,
sphericity, elasticity
Single cell technique Labor intensive
Holographic optical
tweezers (HOT)
(Steffen et al., 2011;
Kaestner et al., 2012)
Usage of highly focused to
generate laserbeams to with
attractive or repulsive forces.
Depending on set-up;
fluidity, elongation,
fluorescence
microscopy read-out
[e.g., Ca2+ (fluo-4-AM)]
Low forces can be
applied
Advanced equipment needed and
labor extensive, no gold standard
Microfluidics
(Cluitmans et al., 2014;
Guo et al., 2014;
Danielczok et al., 2017;
Picot et al., 2015)
RBC suspension is injected in
network of microfluidic
channels. In these channels
RBC are subjected to small
pores where RBC deformability
is essential.
Depends on
microfluidic set-up
Measurement of
individual RBCs, RBC
deformability measured
under relative
physiological
conditions, various
set-ups available
Technique still in development
phase, no gold standard available,
which hampers comparison
between laboratories and reduces
interlaboratory reproducibility.
RBCs can block microfluidic device
RBC filterability (Oonishi
et al., 1997)
RBC needs to pass filter with
various pore-sizes. Also various
columns are used with different
particle and particle sizes (e.g.,
cellulose, metal beads).
Dependent on set-up:
time, lysis, resistance
Relatively easy
technique
No standardization available and no
standardized commercial technique
available. No comparison between
laboratories possible. Can be
affected by parameters such as
MCV.
channel function lead to increased intracellular levels of Ca2+
and subsequent KCNN4 (Gardos channel) activation (Cahalan
et al., 2015; Danielczok et al., 2017). KCNN4 activation leads to
eﬄux of K+ and dehydration. The relatively low intracellular
levels of K+ could therefore serve as a biomarker for HX
(Zarychanski et al., 2012; Gallagher, 2017). Although PIEZO1
mutations leads to KCNN4 (or Gardos channel) activation, RBCs
with mutations in KCNN4 (Gardos channelopathy) exhibit a
different pathology (Fermo et al., 2017a). For example, HX caused
by mutations in PIEZO1 lead to severe RBC dehydration, which
is also shown by a left-shift of Ohyper in the osmotic gradient
curve (see Figure 1B and see section “Techniques to Determine
RBC Deformability”) while mutations in KCNN4 (or Gardos
channel) may cause only slight alterations in the osmotic gradient
curve (Fermo et al., 2017b). In addition, RBCs from patients
with KCNN4 mutations were found to exhibit increased activity
of Na-K-ATPase that is most likely triggered by the increase
in the intracellular Na+ concentrations. The hyperactivated Na,
K-pump compensates for the dissipation in Na/K gradients and
pumps K+ back into the cells, but fails to restore normal K+
content completely (Fermo et al., 2017a). Currently, however, it
is difficult to measure intracellular water content or RBC volume
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FIGURE 2 | schematic overview of RBC ion pumps (Sachs, 2003; Tiffert et al., 2003), symporters and antiporters (Bernhardt et al., 1988; Wolfersberger, 1994) and
ion channels (Bouyer et al., 2012; Kaestner, 2011, 2015).
directly and accurately enough, which makes it challenging to
discriminate between water loss and membrane loss.
Cytoskeletal Network
Primary Changes of the Cytoskeletal Network
In addition to the protein defects, described above, that directly
disturb the membrane and thereby the ability of the RBC to
deform there are also secondary causes affecting membrane
(protein) function and, thereby, RBC deformability. Examples of
these are membrane protein phosphorylation, RBC density and
RBC vesiculation.
The RBC membrane is built from a basic triangular network
of α- and β-spectrin molecules connected to band 3, ankyrin
and protein 4.1 (Perrotta et al., 2008; Salomao et al., 2008).
This network provides the RBC with a certain stability and
simultaneously the ability to deform. HS (HS) is characterized
by defects in proteins forming the cytoskeletal network or
proteins forming ankyrin and junctional complexes. This usually
concerns mutations in band 3, protein 4.2, α-spectrin, or ankyrin
(Perrotta et al., 2008). These mutations lead to membrane
instability, membrane loss through release of hemoglobin-free
vesicles, with consequent decreased surface area-to-volume ratio,
increase in MCHC and density and formation of spherocytes
(Perrotta et al., 2008). Spherocytes show a characteristic loss
of RBC deformability, leading to premature removal of these
RBCs from the circulation (Perrotta et al., 2008). Hereditary
elliptocytosis (HE) is a disorder characterized by disturbances of
the horizontal cytoskeletal interactions and are usually caused
by mutations in α-spectrin, β-spectrin and protein 4.1R. As
the name suggests, the disturbed horizontal interactions lead to
the formation of elliptocytes. The majority of HE patients are
clinically asymptomatic, but few patients suffer from hemolysis,
jaundice and splenomegaly (Da Costa et al., 2013).
Secondary Disturbances of the Cytoskeletal Network
The triangular spectrin network, connected through ankyrin
and protein 4.1R to band 3 supports membrane stability and
contributes to RBC flexibility and deformability. Tyrosine
phosphorylation of in the individual proteins regulates
interaction forces between the elements of this network. Tyrosine
phosphorylation is regulated by phosphotyrosine kinases and
by phosphotyrosine phosphatases. Under normal conditions,
protein regulatory tyrosine residues are only phosphorylated to a
limited degree (Terra et al., 1998; Zipser et al., 2002). In the RBC
membrane, phosphorylation of protein 4.1R, for example, leads
to a reduced membrane stability (Muravyov and Tikhomirova,
2013), and phosphorylation of ankyrin regulates its binding to
band 3 (Muravyov and Tikhomirova, 2013). The dissociation
constant (Kd) between ankyrin and band 3 influences RBC
deformability without a loss in elasticity, underlining that
cytoskeletal protein phosphorylation has implications on RBC
deformability (Anong, 2006).
The effect of phosphorylation of band 3, the most abundant
membrane protein, on RBC deformability is not entirely clear.
The possible physiological relevance of band 3 protein Tyr
phosphorylation state emerges from the fact that it is controlled
by hormones such as insulin (Marques et al., 2000) and that it is
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altered in patients with hemoglobinopathies (Terra et al., 1998).
Saldanha et al. (2007) showed that dephosphorylation of band
3 Tyr residues does not affect RBC deformability. It, therefore,
appears that phosphorylation of band 3 does not affect RBC
deformability directly, but may alter band 3 protein aggregation
and its interaction with extracellular matrix components.
Lopes de Almeida et al. (2012) showed that high
concentrations of fibrinogen in combination with
dephosphorylated band 3, leads to mildly increased RBC
deformability at low shear stress. In contrast to these findings,
Reid et al. (1984) report decreased RBC deformability in
diabetic patients with hyperfibrinogenemia in absence of
dephosphorylating agents (Reid et al., 1984). The decreased RBC
deformability in the absence of dephosphorylating agents seems
to underline that phosphorylation is not involved. However,
insulin is implicated in the activation of tyrosine kinases that in
turn phosphorylate band 3. In diabetes types I and II, glucose
and insulin homeostasis is disturbed leading to increased
protein tyrosine phosphatase activities and aberrant band 3
phosphorylation patterns (Marques et al., 2000), potentially
leading to reduced RBC deformability and increased RBC
turnover. This same principle may also play a role in patients
with sepsis, where investigators have shown that tyrosine
phosphorylation of band 3 was increased in septic mice and that
this increase was accompanied by reduced RBC deformability
(Condon et al., 2007).
Band 3 phosphorylation was found to be increased by a
rise in intracellular Ca2+-concentrations due to dissociation of
phosphotyrosine phosphatase from band 3 (Zipser et al., 2002).
Interestingly, sickle cell disease is characterized by an increase in
both intracellular Ca2+ concentration (Bogdanova et al., 2013)
and tyrosine phosphorylation of band 3 (Terra et al., 1998),
which potentially could thus influence RBC membrane stability.
The importance of band 3 phosphorylation for RBC shape and
deformability is highlighted by a number of in vitro experiments.
For example, morphological changes of RBCs were observed
after Tyr-phosphorylation of band 3 mediated by pervanadate
(Bordin et al., 1995). In contrast, Ser/Thr-phosphorylation of
spectrin, which was selectively induced by okadaic acid did
not result in morphological changes (Bordin et al., 1995).
Unfortunately, the deformability of RBCs after pervanadate and
okadaic treatment was not measured in these studies, but it seems
reasonable to assume that RBC deformability is affected since
both membrane protein phosphorylation and RBC morphology
have been associated with altered RBC deformability (Reid et al.,
1984; Chabanel et al., 1987; Hasegawa et al., 1993; Saldanha et al.,
2007; Lopes de Almeida et al., 2012).
RBC Hydration Changes Associated With
Cytoskeletal Defects
Although reduced RBC deformability in HS mainly results from
cytoskeletal disturbances (Perrotta et al., 2008), spherocytes
experience dehydration and increased leakage of K+ (De
Franceschi et al., 1997; Gallagher, 2017). To compensate for
this increased K+ leakage, spherocytes are also found to have
increased activity of the Na-K pump and the NKCC1 (also known
as the Na-K-2Cl cotransporter, coded by gene SLC12A2) (Vives
Corrons and Besson, 2001). RBCs of transgenic mice deficient for
ankyrin or spectrin show increased activity of the Na-K pump,
but normal activities of the NKCC1 and K+-Cl− cotransporters
(Peters et al., 1999). This contrasts with protein 4.2-deficient
mice, where Na-K pump activity is normal, while activities of
NKCC1 and K+-Cl− cotransporters are increased (Peters et al.,
1999). These differences in pump activities between protein 4.2
deficient and spectrin- or ankyrin-deficient mice support the
concept that membrane proteins interact with ion channels of the
RBC.
The RBC dehydration in HS also involves increased
intracellular Ca2+ levels (Hertz et al., 2017). Increased
intracellular Ca2+ correlates with decreased RBC deformability
and RBC membrane stiffening (Bogdanova et al., 2013). For
example, after in vitro ATP-depletion of HS RBCs, Ca2+ influx
is increased compared to healthy RBCs (Shimoda et al., 1984).
The detailed mechanisms beyond this Ca2+ influx have up to
now not been identified and may include PIEZO1 or NMDA
receptors both of which are activated by shear stress in “stiff” less
deformable cells.
In protein 4.2−/−mice, displaying the HS phenotype, KCNN4
(or known as Gardos channels in RBCs) were noted to be
functionally up-regulated, or at least more KCNN4 activity was
measured (Peters et al., 1999; De Franceschi et al., 2005). This
can be considered as a protective mechanism that leads to an
outward flux of K+ and water from RBCs. This mechanism
may compensate for the decreased surface-to-area ratio. Indeed,
increased lysis was observed when these RBCs were exposed to
KCNN4 (or Gardos-channel) inhibitors (De Franceschi et al.,
2005). These findings indicate that KCNN4 is activated in
HS in order to facilitate RBC dehydration, which maintains
hemoglobin in RBCs at the expense of water. Recent research
confirms the finding that RBC dehydration and formation of
denser RBCs may protect the RBC in HS from lysis and
premature uptake. We observed that mild HS is accompanied
with prolonged RBC life-span, relatively mild reductions in RBC
deformability and denser RBCs when compared with RBCs
from patients with moderate/severe HS (Huisjes et al., 2017a).
Most likely, the mild reduction in RBC deformability in patients
with mild HS avoids premature splenic uptake and thus may
provide the HS RBC time to lose membrane and to become
dense.
Red Cell Metabolism
Primary Changes of Red Cell Metabolism
Mature RBCs of healthy individuals lack mitochondria and are
therefore entirely dependent on the glycolytic pathway for the
production of energy in the form of ATP. In the glycolytic
pathway, glucose is converted to lactate by several enzymatic
steps (Figure 3) (van Wijk and van Solinge, 2005; Koralkova
et al., 2014). Key regulatory enzymes in the glycolytic pathway
are HK, phosphofructokinase and PK. Hereditary metabolic
disorders, or enzymopathies, are disorders impairing cellular
energy production and balance, in particular ATP production.
ATP is essential in the regulation of RBC deformability,
viability, regulatory cascades involving phosphorylation and
activity of ion transport involving Na, K-ATPase, and Ca
Frontiers in Physiology | www.frontiersin.org 7 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 8
Huisjes et al. Properties of RBC Deformability
FIGURE 3 | Glycolytic pathway of RBCs is essential for energy metabolism as RBCs lack mitochondria and a nucleus. Enzyme deficiencies can lead to decreased
intracellular ATP levels, which possibly reduce RBC deformability. Depicted here are the Embden–Meyerhof pathway, hexose monophosphate shunt and the
influence of a pyrimidine 5′-nucleotidase deficiency. Red arrows illustrate negative feedback or reduced production. This illustration is a merged figure adapted from
both van Wijk and van Solinge (2005) and Zanella et al. (2006).
ATPase (Weed et al., 1969; Tuvia et al., 1998; Martinov et al.,
2000; Fischer et al., 2003; Park et al., 2010; Makhro et al.,
2016).
Adenosine triphosphate plays a key role in maintenance of
ion gradients and should impact cytoskeletal structure and RBC
shape (Tuvia et al., 1998; Park et al., 2010). However, glycolytic
enzymopathies usually do not show altered RBC morphology
(Koralkova et al., 2014; Huisjes et al., 2017b). For reasons that
are not yet well understood, metabolically defective RBCs are
prematurely removed by the spleen, causing chronic Hereditary
Non-Spherocytic Hemolytic Anemia (HNSHA) (Koralkova et al.,
2014).
Several observations point to mechanisms that may be
involved in the premature clearance. RBCs from a patient with
pyruvate kinase deficiency (PKD) were found to leak K+ more
rapidly and were found to consume ATP at an accelerated
rate (Nathan et al., 1965). This most likely contributes to the
decreased RBC viability in this disease and could result in reduced
RBC deformability (Leblond et al., 1978). A possible explanation
for increased clearance of RBCs with metabolic defects is the
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FIGURE 4 | cAMP production by adenylyl cyclase (AC). AC is activated after stimulation by G-protein coupled receptors (GPCR) and converts ATP to cAMP.
Examples of GPCRs 2-adrenergic receptor, the lysophosphatidic β in RBCs are the erythrocyte acid (LPA) receptor and the purinergic (P2Y) receptor. cAMP acts as
a second messenger in RBCs and among other things stimulate protein kinase A (PKA). Under low ATP concentrations, AMP-activated protein kinase (AMPK)
becomes active and can inactivate or activate yet not fully understood processes in RBCs.
imbalance in Ca2+ uptake and extrusion (Bogdanova et al.,
2013; Hertz et al., 2017). In agreement with the hypothesis
that ATP deprivation will cause Ca2+ overload due to the
inability to actively extrude Ca2+ from the cells by the Ca2+
pumps, decreased ATP levels in RBCs with metabolic defects
were associated with abnormally high intracellular Ca2+ and
exposure of PS, an important cellular ‘eat-me’ signal (de Back
et al., 2014). Alternatively, defective metabolism may impact the
redox state of RBCs making them more susceptible to oxidative
stress (Cappellini and Fiorelli, 2008).
Despite the intuitive feeling that intracellular ATP levels
should correlate with cellular deformability, evidence for this is so
far inconclusive. This may be related to the techniques used. For
example, research performed by Karger et al. (2012) did not show
any correlation between intracellular ATP and deformability
in RBC-concentrates intended for transfusion when assessing
deformability by increasing shear stress. On the other hand,
studies using viscosity and filterability assays did find correlations
between intracellular ATP and deformability and showed that
deformability is indeed dependent on intracellular ATP levels
(Weed et al., 1969; Fischer et al., 2003). Atomic force microscopy
studies also revealed increased membrane stiffness after ATP
depletion due to reduced spectrin phosphorylation (Picas et al.,
2013). We hypothesize that the different results from these
experiments are possibly caused by the fact that ATP is not
required for RBCs to elongate after the application of external
forces, such as shear stress but ATP might be essential in the
process of RBC deformation toward different shapes, as seen in
filterability measurements.
Secondary Changes of Metabolism
Cyclic AMP (cAMP) is a second messenger and is derived
from ATP. In nucleated human cells, cyclic AMP (cAMP)
is synthesized from ATP by adenylate cyclase (AC) upon
stimulation by G-protein coupled receptors (GPCR) and there is
evidence that this process also occurs in human RBCs (Oonishi
et al., 1997; Tuvia et al., 1999; Sprague et al., 2006; Kostova
et al., 2015) (see Figure 4). Examples of GPCRs on RBCs are
the erythrocyte β2-adrenergic receptor (Harrison et al., 2003), the
lysophosphatidic acid (LPA) receptor (Wang et al., 2013) and the
purinergic (P2Y) receptor (Kostova et al., 2015). The activation
of the erythrocyte β2-adrenergic receptor by catecholamines such
as epinephrine (or adrenaline) affects RBC deformability (Tuvia
et al., 1999). In vitro experiments with increased concentration
of adrenaline, lead to increased membrane fluctuations and
increased RBC filterability (Tuvia et al., 1999).
Intracellular mechanisms that sense and control cellular
energy status in RBCs
Phosphodiesterases tightly regulate levels of cAMP in RBCs
(Adderley et al., 2011). PDEs catabolize the phosphodiesters in
cyclic nucleotides, such as cAMP to AMP or cGMP to GMP.
By inhibiting these PDEs, cyclic nucleotides remain intact and
active. The reports of cAMP effects on RBC deformability are,
however, ambivalent. Recently it was found that sildenafil, which
is a PDE inhibitor and well-known for its function in the
treatment of erectile dysfunction and pulmonary hypertension,
has beneficial effects on RBC deformability in sickle cell disease
at low concentrations in vitro. Increase in nitric monoxide
bioavailability was suggested to improve RBC deformability
(Grau et al., 2013; Kuhn et al., 2017). However, increased
concentrations of sildenafil impaired sickle RBC filterability
(Hagley et al., 2011). Typically, inhibition of cGMP-specific PDE
type 5 (PDE-5) by sildenafil reduces the degradation of the
second messenger cGMP to GMP and increases smooth muscles
relaxation. In RBCs, this PDE-5 inhibition increases not only
intracellular levels of cGMP but also preserves intracellular levels
of cAMP via the inhibitor activity of cGMP on PDE-3 (see
Figure 5) (Adderley et al., 2010; Knebel et al., 2013). The effect
of increased cAMP levels was also studied using a spleen-like
microfiltration system. Increased retention in the microfiltration
system, reflecting decreased deformability, was observed after
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FIGURE 5 | effect of PDE-5 inhibitors, such as sildenafil, on RBC
deformability. PDE-5 inhibitors elevate intracellular concentrations of cGMP,
thereby indirectly inhibiting PDE3. Inhibition of PDE3 does raise the intracellular
concentration of cAMP. Depending on the degree of this intracellular cAMP
elevation, RBC deformability can be either increased or decreased.
incubation of RBCs with sildenafil (Ramdani et al., 2015).
Moreover, the production of cGMP from GTP is synthesized
by guanylate cyclase (Derbyshire and Marletta, 2012). Guanylate
cyclase is activated by nitric oxide (NO) and the addition of
sodium nitroprusside to RBCs as an artificial nitric oxide donor
does prevent Ca2+ influx and Ca2+-mediated stiffness of RBCs
(Barodka et al., 2014).
In addition, the effect of cAMP on the release of ATP is still
under debate. A role for cAMP in the release of ATP to its
extracellular environment via PKA was proposed (Sprague et al.,
2007; Adderley et al., 2011; Knebel et al., 2013) (see Figure 4).
Others, however, have attributed the release of ATP solely to
hemolysis of the RBC (Sikora et al., 2014) or to release via
transporters such as Pannexin 1 (Locovei et al., 2006) or PIEZO1
(Cinar et al., 2015).
Recently AMPK was also found to be present in RBCs
(Thali et al., 2010). The exact function of AMPK in RBCs
is unknown, however, in other cells, AMPK is essential to
balance ATP consumption and ATP production. In muscles
and fat AMPK regulates glucose uptake (Mihaylova and Shaw,
2011). Likely, AMPK also regulates these processes in RBCs,
as RBCs from AMPK−/− mice were less viable after in vitro
glucose depletion (Föller et al., 2009). Interestingly, these
AMPK−/− mice had increased reticulocytes count, decreased
RBC deformability, increased osmotic fragility, increased spleen
size and decreased RBC lifespan (Foretz et al., 2010; Wang et al.,
2010). This indicates a significant contribution of AMPK in
maintaining RBC function and viability. AMPK is an energy-
sensing enzyme, which is activated by low AMP: ATP ratios
and inhibited by high AMP: ATP ratios (Wang et al., 2003).
Under low ATP concentrations, AMP and ADP can bind to
AMPK and change its conformation, thereby preventing the
protein from activation by phosphorylation (Mihaylova and
Shaw, 2011). Chemical agents that increase intracellular levels
of cAMP are forskolin and isobutyl-methyl-xanthine (IBMX).
Forskolin activates AC and thus leads to increased formation
cAMP from ATP, while IBMX inhibits PDEs and maintains
cAMP levels. Both forskolin and IBMX lead to AMPK inhibition,
which reveals a molecular interaction between cAMP and
AMPK activity (Hurley et al., 2006). This interaction could
play a role in altered deformability in patients suffering from
glycolytic enzymopathies. The low RBC ATP concentrations
in these patients would lead to low levels of cAMP and
increased intracellular levels of non-phosphorylated (inactive)
AMPK.
Phosphorylation of AMPK may also be involved in G6PD-
deficiency. G6PD deficiency is the most common RBC enzyme
deficiency with over 400 million affected people (Cappellini
and Fiorelli, 2008). Deficiency of this enzyme is associated
with decreased ability of the RBC to withstand oxidative stress
(Cappellini and Fiorelli, 2008; Mangat et al., 2014; Tang et al.,
2015). Exposure of normal and G6PD-deficient RBCs to the
oxidant diamide leads to a decrease in RBC deformability of the
G6PD-deficient RBCs due to the inability of the RBC to maintain
the intracellular glutathione-pool (Tang et al., 2015). Depletion of
glutathione also leads to activation of AMPK by phosphorylation
in G6PD-deficient RBCs. The activation of AMPK in G6PD-
deficient RBCs after exposure to oxidative stress is most likely a
consequence of ATP-consuming compensation mechanisms after
excessive glutathione loss (Tang et al., 2015).
Protein kinase C alpha (PKCα) possibly also regulates RBC
deformability. PKCα is involved in the phosphorylation of
proteins in the RBC, such as adducin, protein 4.1R and protein
4.9 (George et al., 2010). Moreover, PKCα is involved in
stimulation of glucose uptake by phosphorylation of the glucose
transporter and participates in the activity of calcium channels
(Kanno et al., 1995; George et al., 2010; Wagner-Britz et al.,
2013). Consequently, phosphorylation and dephosphorylation of
these proteins can be altered upon depletion of glucose. Glucose
depletion was found to activate PKCα and this is accompanied
by an increase in intracellular Ca2+ and, consequently, exposure
of the membrane phospholipid PS (Klarl et al., 2006). The
phosphorylation of adducin and protein 4.1R by PKCα could
change RBC behavior and could influence RBC deformability
(George et al., 2010) in a way similar to what is seen, for
example, after phosphorylation of band 3 (Saldanha et al., 2007).
Interestingly, homology analysis between murine, rat and human
showed a conserved region in both liver- and RBC-specific PK
for a PKCα binding site (Kanno et al., 1995). PKCα regulates
RBC membrane stability and this conserved region for PK
indicates a possible role for PK in this process (Kanno et al.,
1995). In addition, PK converts phosphoenolpyruvate (PEP) to
pyruvate (Figure 3) and previously it has been recognized that
phosphorylation of PK by cAMP-dependent protein kinases leads
to a reduced affinity of PEP for PK, which leads to a reduced
production of ATP (Marie et al., 1980). The decreased cAMP
and ATP production in metabolic disorders of the RBC, such
as PK-deficiency, could subsequently result in disturbed RBC
deformability (Leblond et al., 1978).
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Role of purines and pyrimidines in RBC deformability
It has been suggested that pools of ATP are intracellular enclosed
by the membrane proteins ankyrin, β-spectrin, band 3, and
GAPDH, serving as substrates for both the Na+, K+-, and
Ca2+ -pumps (Chu et al., 2012). This indicates an interplay
between membrane proteins, energy stores and ion channel
function of the RBC. Interestingly, the chemotherapeutic agent
5-FU was shown to induce changes in RBC rigidity, morphology
and ion balance, most likely by altering ATP levels in the
RBC (Spasojevic´ et al., 2005). 5-FU is a pyrimidine antagonist
(Longley et al., 2003) and since purine and pyrimidines play
key roles in cellular metabolism and energy homeostasis. 5-FU
could, therefore, influence RBC deformability. The activating and
feedback mechanisms of purines and pyrimidines on glycolytic
enzymes have previously been described by Seider and Kim
(1979) and Tomoda et al. (1982). For example, in bovine RBCs
incubated with glucose, adenosine stimulated ATP production
compared to incubation with glucose alone. Most likely, adenine
(i.e., the nucleobase of adenosine) stimulates HK activity (Seider
and Kim, 1979). The effect of pyrimidines in RBCs has also
been studied in two patients with a pyrimidine 5′-nucleotidase
(P5N) deficiency, which lack this enzyme involved in clearance of
pyrimidines from the RBC. P5N deficiency increases intracellular
concentrations of pyrimidine nucleotides, which eventually leads
to hemolytic anemia (Vives L Corrons, 2000). P5N-deficient
patients were also found to have increased levels of reduced
glutathione (Tomoda et al., 1982). At the same time, pyrimidine
5′-nucleotides (such as cytidine mono-, di-, and triphosphate
(CMP, CDP, CTP) or uridine mono-, di-, and triphosphate
(UMP, UDP, UTP)) decreased the activity of glucose-6-phosphate
dehydrogenase (G6PD, Figure 3). As mentioned earlier G6PD
activity is crucial in the anti-oxidative defense of RBCs. Indeed,
RBCs from P5N-deficient patients were found to be more
susceptible to oxidative stress, as reflected by increased formation
of Heinz bodies (Tomoda et al., 1982), even despite increased
reduced glutathione concentrations. Besides their role as a
morphological marker of oxidative stress, Heinz bodies can lead
to a decreased deformability by themselves (Hasegawa et al.,
1993).
Hemoglobin
Primary Changes of Hemoglobin
Hemoglobin is the main component of the RBC and responsible
for the delivery and removal of oxygen and carbon dioxide
to and from the tissues, respectively. Intracellular hemoglobin
concentrations and its state (polymerization, crystallization,
degradation, and oxidation) also defines cytosolic viscosity
making up 19.9–22.3 mmol/L in cells of healthy humans.
Hemoglobin is composed of two α- and β-hemoglobin molecules
together composing a heterotetramer. Disorders of hemoglobin
can be subdivided into hemoglobinopathies (e.g., sickle cell
anemia) and thalassemias (α- and β-thalassemia) (Galanello and
Origa, 2010; Harteveld and Higgs, 2010; Higgs et al., 2012; Ware
et al., 2017).
Sickle cell anemia is caused by a single point mutation in
the HBB gene at position 6 substituting glutamic acid to valine
(HbS). This substitution causes formation of HbS polymers
of deoxygenated hemoglobin. This transition is usually rapidly
reversed upon reoxygenation, but induces progressive damage
of membrane driving dehydration to the extreme to the state
when HbS polymers do not dissociate as its concentration exceeds
it solubility threshold. Destabilization of the membrane and
decrease in deformability leads to intravascular hemolysis and to
vaso-occlusive events (Ware et al., 2017). Sickle RBCs are poorly
deformable (Alapan et al., 2015, 2016) and this is, in part, due to
changes in hydration status of the RBC.
In α- and β-thalassemia, α- and β-hemoglobin chains are
affected, respectively, which leads to an imbalance in the synthesis
of globin chains and to an inability to form sufficient quantities
of hemoglobin heterotetramers. The imbalanced synthesis in
thalassemia leads to the formation of hemoglobin precipitates,
so-called Heinz bodies. RBCs in α-thalassemia show increased
hydration (Bunyaratvej et al., 1994; Chui et al., 2003), whereas
the hydration of RBCs in β-thalassemia is either decreased or
increased (Bunyaratvej et al., 1994; Brugnara and Mohandas,
2013). Both Heinz bodies and the altered hydration state of the
RBC are known to impair RBC deformability (Clark et al., 1983;
Losco et al., 2001).
Oxygenation of Hemoglobin
The main function of RBCs is to transport oxygen to the tissues
in the human body. The oxygenation state of hemoglobin is
known to influence various processes of the RBC (Gibson et al.,
2000; Stefanovic et al., 2013). Several ion transporters are oxygen
sensitive, such as K+-Cl− cotransporter (KCC1) and the NKCC1
(Na-K-2Cl cotransporter) (Bogdanova et al., 2009). The function
of band 3 seems, however, unaltered upon deoxygenation and
oxygenation (Gibson et al., 2000). On the other hand, hemoglobin
binds the cytosolic domain of band 3 and this binding is
regulated by pH (Eisinger et al., 1982; Chétrite and Cassoly,
1985). Deoxygenation reduces the binding of ankyrin to band 3
and dissociation leads to more freely diffusible band 3 (Stefanovic
et al., 2013). In addition, the binding between ankyrin and
band 3 is also regulated by 2,3-disphosphoglycerate (2,3-DPG)
(Moriyama et al., 1993). 2,3-DPG promotes the dissociation of
oxygen from hemoglobin and promotes the release of oxygen
from the RBC to the tissues (van Wijk and van Solinge, 2005).
In the oxygenated state 2,3-DPG is not bound to hemoglobin
and leads to less deformable and more fragile RBCs, while in
the deoxygenated state 2,3-DPG is bound to hemoglobin and
leads to an increase in RBC deformability and less fragile RBCs
(Moriyama et al., 1993). The exact role of the reduced binding
between ankyrin and band 3 after deoxygenation and binding
of 2,3-DPG to hemoglobin is currently unknown, although it is
hypothesized that a mild membrane weakening is beneficial in
deoxygenated capillaries to facilitate smooth traveling of the RBC
(Stefanovic et al., 2013).
RBC Hydration Changes Associated With
Hemoglobin Defects
RBC dehydration in sickle cell anemia
The RBC dehydration in sickle cell anemia is caused by facilitated
K+ loss through hyperactivated KCNN4 (also known as the
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Gardos Channel in RBCs) and K+-Cl− cotransporter that is not
compensated by uptake of equal amounts of Na+ (Clark et al.,
1982; Izumo et al., 1987). Regardless of the ion transport pathway
involved, RBC dehydration raises the HbS concentration,
thereby affecting the equilibrium of HbS-polymerization and
depolymerization in favor of the polymerized version (Eaton and
Hofrichter, 1990; Brugnara, 1993). Na/K/ATPase was found to
be more active in RBCs from sickle cell disease patients and can
contribute to RBC dehydration (Izumo et al., 1987). Dehydration
of RBCs in sickle cell disease contributes significantly to
the decreased deformability since dehydration promotes the
probability of polymerization of HbS by 20–40-fold (Eaton and
Hofrichter, 1990) and result in prolonged polymerization of
hemoglobin and thus prolonged sickling of RBCs (Brugnara,
1993). Sickled RBCs are far less deformable.
Two mechanisms involved in abnormally high K+ loss are
presented in Figure 6. The first mechanism of K+ loss involves
the ubiquitously expressed K-Cl co-transporter (KCC), of which
the isoforms KCC1, KCC3, and KCC4 are expressed in human
RBCs (Crable et al., 2005).
KCC1, is most often studied in RBCs and referred to as KCC.
KCC in RBCs are known to be regulated by intracellular pH,
Mg2+ concentrations as well as volume and oxygenation states
of hemoglobin (Adragna et al., 2004; Khan et al., 2004). Under
physiological conditions, KCC activation restores cell volume
after swelling, but KCC activation may also respond to the
changes in the RBC redox state (Adragna et al., 2004). In healthy
RBCs, KCC is oxygen sensitive but only activated at high oxygen
tension (pO2). At low oxygen tension, KCC becomes sensitive to
other stimuli (Gibson et al., 1998, 2001; Muzyamba et al., 2006).
In sickle cell disease, in contrast, KCC is also activated at low
oxygen tension, most likely due to increased phosphorylation of
KCC in sickle RBCs (Muzyamba et al., 2006). In addition, KCC
activity is intrinsically higher, even in older sickle RBCs (Bize
et al., 2003).
The loss of deformability caused by the formation of HbS-
polymers at low oxygen tensions (Odièvre et al., 2011) is
enhanced by the KCC activation and leads to additional cell
shrinkage. The clinical relevance of KCC activity is emphasized
by observations in individuals with mild sickle cell disease. In
these patients, an increased K-Cl cotransport activity is associated
with increased likelihood of hospitalization, because of acute
vaso-occlusive problems caused by less deformable dehydrated
RBCs (Rees et al., 2015).
One more trigger of K+ leak from RBCs is the increase
in the intracellular Ca2+ levels and the activation of Ca2+-
sensitive K+ channels (KCNN4 or known as the Gardos
channel in RBCs) (Gallagher, 2017). These channels driving
K+ loss and dehydration are hyperactivated in RBCs of sickle
cell disease patients secondary to the high intracellular Ca2+
levels (Bookchin and Lew, 1980; Bogdanova et al., 2013) (see
Figure 6). KCNN4 is expressed in various cell types (Gallagher,
2013) and are inhibited by imidazole antimycotics, such as
clotrimazole (McNaughton-Smith et al., 2008). In sickle cell
disease, KCNN4 (or known as the Gardos channel in RBCs)
is activated by two pathways. Firstly, KCNN4 can be activated
by a signaling cascade initially triggered by several cytokines,
such as PAF, interleukin-10 (IL-10) and endothelin 1 (ET-
1) (Rivera, 2002) also involving activation of PKCα (Rivera
et al., 1999; Wagner-Britz et al., 2013). In addition, PAF and
ET-1 concentrations are increased in plasma from patients
with sickle cell disease and are assumed to contribute to the
adhesion of sickle RBCs to endothelium that is responsible for
the vaso-occlusive events (Rivera, 2002). Also, these cytokines
generate denser RBCs through RBC dehydration after an
oxygenation/deoxygenation cycle (Rivera, 2002). Secondly, sickle
cell disease patients have increased expression of the NMDA-
receptor on their RBC membranes, causing pathological influx
of Ca2+ after stimulation with receptor agonists (such as
glycine and homocysteic acid) (Hänggi et al., 2014) which could
contribute to dehydration mediated by KCNN4. Currently, a
clinical trial using memantine as a NMDA-receptor antagonist
is being tested in sickle cell disease patients (Bogdanova
et al., 2017). In addition, the KCNN4 (or Gardos channel)
blocker senicapoc (ICA-17043) has recently been tested in sickle
cell disease. Senicapoc increased hemoglobin concentrations
and hematocrit, and improved RBC hydration. Despite these
encouraging findings, this study has been terminated prematurely
because senicapoc did not meet its primary efficacy endpoint,
defined as a decrease in painful crises (Ataga et al., 2011).
From the clinical results obtained with senicapoc it can be
hypothesized that the RBC dehydration and changes in RBC
hydration after treatment with senicapoc are not causally related
to the vaso-occlusive events which are often observed in sickle
cell anemia.
Another pathway that increases intracellular Ca2+ levels in
sickle cell disease is the mechanosensitive PIEZO1 channel (also
described at section “Primary Changes of RBC Hydration”).
PIEZO1 channels are widely expressed in vertebrates across
various cell types and in RBC these channels are responsible
for regulation of volume homeostasis upon mechanical signals
(Zarychanski et al., 2012; Ge et al., 2015). Sickle RBCs
show increased permeability for Ca2+ and Mg2+ upon
deoxygenation. This increased permeability results in an
increased deoxygenation-induced cation conductance in sickle
cell disease, which can be entirely blocked by GsMTx4 (Ma et al.,
2012; Cahalan et al., 2015). The gating modifier GsMTx4 blocks
the mechanically sensitive part of PIEZO1 that supports a closed
state of this ion channel (Bae et al., 2011), preventing Ca2+ influx
(Jacques-Fricke et al., 2006).
RBC hydration changes in thalassemia
Three increasingly severe phenotypes can be distinguished in
β-thalassemia, i.e., β-thalassemia minor, intermedia and major
(Higgs et al., 2012). Intracellular concentrations of Na+ in RBCs
from patients with β-thalassemia minor and β-thalassemia major
are comparable with those in RBCs from healthy adults, but K+
levels are slightly increased (Cividalli et al., 1971). Upon in vitro
incubation at 37◦C, RBCs from patients with β-thalassemia major
show increased leakage of K+ and elevation of intracellular
Na+ levels when compared with healthy RBCs. In RBCs from
β-thalassemia minor patients, leakage of K+ and intracellular
Na+ levels are comparable to the healthy RBCs after in vitro
incubation at 37◦C (Cividalli et al., 1971).
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FIGURE 6 | RBC dehydration in sickle cell disease. The Na-K pump (Na, K-ATPase) is more active in sickle RBCs, leading to dehydration as extrusion of 3 Na+ ions
leads to the influx of 2 K+ ions. Dehydration of sickle cell is initiated by PIEZO1 activation, likely because PIEZO1 is stretch-activation after deoxygenation (Ma et al.,
2012). Dehydration in sickle cell disease is also initiated by the upregulation of the NMDA receptor. Both the NMDA receptor and PIEZO1 activation result in Ca2+
influx that leads to KCNN4 activation (KCCN4 in RBCs is better known as the Gardos channel). Gardos channel activation in sickle cell disease is also achieved by
signaling cascades which respond to increased levels of cytokines. This leads to K+ and water efflux by aquaporins (AQ1). In sickle cell disease, the K-Cl
cotransporter is also activated at low oxygen tensions, causing efflux of K+ and subsequently loss of water by aquaporins (AQ1), while under normal conditions KCC
is only active at normal pO2. Although water can be cotransported through KCC1 (Zeuthen and Macaulay, 2012), water efflux in RBCs mainly driven by aquaporins
(AQ1).
Leakage of K+ from RBCs in thalassemia is possibly linked to
the precipitation of excess α- or β-globin chains inside the RBCs,
which is a characteristic feature of this disease. The precipitated
globin chains in RBCs can lead to oxidative stress and can
affect transport of Na+ and K+ in thalassemia RBCs (Olivieri
et al., 1994). In both β-thalassemia and α-thalassemia, RBCs
show increased eﬄux of K+ (Olivieri et al., 1994). Moreover,
the amount of hemoglobin aggregates in RBCs is correlated
with K+ eﬄux (Nathan and Gunn, 1966). The presence of these
aggregates reduces RBC deformability (Lubin and Desforges,
1972; Hasegawa et al., 1993) thereby revealing correlation
between K+ fluxes, Heinz body formation, and reduced RBC
deformability. The precipitation of globin chains and leakage of
K+ from RBCs in thalassemia is also linked, or may even be
augmented, by overload of Ca2+ (Shalev et al., 1984; Bookchin
et al., 1988).
Another important factor in K+ loss from RBCs in
β-thalassemia involves the K+-Cl− cotransporter, which can be
affected by oxidative stress (Olivieri et al., 1994). This K+ loss by
the K+-Cl− cotransporter is inhibited by increased intracellular
concentrations of Mg2+ (De Franceschi et al., 1998; Adragna
et al., 2004). In a trial with β-thalassemia intermedia patients,
dietary Mg2+ supplementation did lead to increased intracellular
concentrations of Mg2+ and to a reduction in the activities
for the K+-Cl− cotransporter and Na-K pump (Na/K/ATPase).
However, Mg2+ did not influence the activities of NKCC1 (also
known as the Na-K-Cl cotransporter). Although dietary Mg2+
supplementation in β-thalassemia patients does not influence the
hemoglobin concentration in blood, it does lead to a significant
decrease in the absolute reticulocyte number. This is possibly due
to improved RBC survival time (De Franceschi et al., 1998).
Little research has been performed on KCNN4 (or also
known as the Gardos channel in RBCs) in thalassemia. An
exception is the work on a mouse model with a homozygous
deletion in the β-globin chain (de Franceschi et al., 1996). These
mice were treated with clotrimazole, an antifungal imidazole
derivate with KCNN4 blocking properties. During treatment
with clotrimazole, hemoglobin concentrations in blood remained
constant. In addition, it caused a decrease in MCHC whereas
hematocrit and intracellular K+ levels increased indicating that
hydration state of the RBC was restored. Combination of
clotrimazole with erythropoietin administration did increase
hemoglobin levels in these mice to a higher extent than
erythropoietin alone, possibly by promoting proliferation and
differentiation during erythropoiesis (de Franceschi et al., 1996).
RBC Vesiculation
Intracellular levels of Ca2+ tightly regulate RBC vesiculation and
elevated levels of intracellular Ca2+ are known to induce PS
exposure and RBC vesiculation (Bevers et al., 1992; Nguyen et al.,
2011; Fens et al., 2012; Alaarg et al., 2013) (Figure 7).
The RBC-vesiculation is a physiological process and leads
to reduced RBC deformability. During its 120-day life span,
RBC lose membrane surface and hemoglobin content through
vesiculation (Werre et al., 2004; Ciana et al., 2017) a process
in particular prominent in the youngest RBCs (Greenwalt and
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FIGURE 7 | Red blood cell vesiculation is driven by increased concentrations of intracellular Ca2+. Phosphatidylserine (PS) is normally presented in the inner-leaflet
of the RBC. Elevated intracellular Ca2+ levels activate scramblase and inhibit flippase, leading to phosphatidylserine (PS) externalization and redistribution of
membrane and cytoskeletal proteins. PS externalization and protein redistribution leads to vesicle formation and loss of RBC deformability (Alaarg et al., 2013).
Dumaswala, 1988). As membrane is shed, this leads to a
decreased surface-to-volume ratio in the RBC. During this RBC
aging, hemoglobin-free vesicles are shed which leads to RBC
dehydration and older RBCs with increased MCHC (Bosch et al.,
1994; Bosman, 2013). Altogether, this leads to a reduction in
membrane elasticity and RBC deformability (Linderkamp et al.,
1993; Bosch et al., 1994). This implies that there is an important
role for vesiculation in RBC deformability.
While RBC-vesiculation is considered a physiological process,
RBC vesiculation is increased in various forms of hereditary
hemolytic anemia, such as HS and sickle cell disease (Perrotta
et al., 2008; Alaarg et al., 2013). In HS, differences in deformability
between spectrin/ankyrin-deficient and band 3-deficient RBCs
were observed after splenectomy. While splenectomy prevented
premature removal of young RBCs from the circulation in
both groups, the loss of deformability during RBC-aging
was delayed after splenectomy in spectrin/ankyrin-deficient
RBCs. This contrasts with band 3-deficient RBCs, where
splenectomy did not lead to a delay in the deformability decrease
during RBC-aging. This could be explained by the fact that
spectrin/ankyrin-deficient RBCs are more prone to shed band
3-containing vesicles. Clustered band 3 is known to induce
binding of autologous IgG, which facilitates removal of RBC by
macrophages (Kay et al., 1983; Kay, 1984; Willekens et al., 2008).
Shedding of band 3-containing vesicles from spectrin/ankyrin-
deficient RBCs, therefore, would avoid IgG-opsonisation and
clearance of the RBC (Reliene et al., 2002).
Red blood cell vesiculation is suggested as a mechanism
to protect the cell from removal from the circulation. By
vesiculation, the RBC can shed “eat-me” signals such as PS
and specific band 3 cleavage products that react with senescent
antigens (Willekens et al., 2008). By shedding these “eat-me”
signals, the RBC may escape clearance until the reduction in
RBC deformability causes trapping in the spleen. In addition,
the lipid bilayer of the RBC is a complex system with various
microdomains. These microdomains of the RBC, or so called
‘lipid rafts’ are specific membrane parts with high concentrations
of cholesterol, sphingomyelin and gangliosides (Pike, 2003).
These specific lipid rafts have a high abundance of the membrane
proteins stomatin, flotillin-1, flottilin-2 (Salzer and Prohaska,
2001) and band 3 (Cai et al., 2012). RBC vesicles shed during
storage are enriched in the lipid raft marker stomatin (Salzer et al.,
2008) and indicates that specific lipid domains are shed during
RBC vesiculation (Leonard et al., 2017).
The relationship between vesiculation and deformability is
nicely illustrated by an experiment where chlorpromazine is
added to RBCs to stabilize the RBC membrane. During overnight
incubation with chlorpromazine at 37◦C in a glucose-free buffer,
vesiculation is inhibited and RBC deformability is maintained.
Without chlorpromazine strong vesiculation of RBCs under these
conditions occur as PS is exposed on the RBC surface. The
activity of chlorpromazine may be explained by the amphiphilic
properties of the molecule directly affecting the RBC membrane
(Bütikofer et al., 1989).
High-throughput screening with chemical compound
libraries also revealed that RBC-vesiculation can be driven by
drugs and chemical compounds. For example, vesiculation
of RBCs is driven by certain kinase pathways, including Jak-
STAT and protein kinase B. Increased RBC vesiculation is also
observed after addition of paclitaxel to blood, probably through
its formulation excipient containing Cremophor. Not only RBC
vesiculation is influenced by the vehicle Cremophor, but the
compound also increases whole blood viscosity and transforms
RBC to stomatocytes (Vader et al., 2013).
Adaptive Responses
Exercise leads to increased heart rate as a response to provide
tissues with sufficient amount of oxygen. Exercise is accompanied
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with several stress factors that may affect RBC deformability, such
as shear stress, hyperthermia, and glucose consumption (Carlson
and Mawdsley, 1986; Szygula, 1990; Smith, 1995; Mairbäurl,
2013). These stress factors can lead to mechanical rupture,
stimulated erythropoiesis and can decrease the average RBC age
in athletes (Mairbäurl, 2013).
In a study with 24 trained cyclists, RBC deformability was
decreased directly after exercise (Oostenbrug et al., 1997).
The biology beyond the decrease in RBC deformability is
unknown, although increased blood flow may be involved.
The change in deformability after exercise can be the results
of cytoskeletal changes, such as membrane loss. In addition,
decreased levels of haptoglobin and increased levels of bilirubin
were observed after marathon races (Jordan et al., 1998; Simpson
et al., 2006). On the other hand, RBC deformability seems
to be generally increased in well-trained athletes (Mairbäurl,
2013). A study comparing RBC membrane fluidity with the
RBC membrane composition in controls and runners observed
increased RBC membrane fluidity in endurance runners and
sprinters. Although the intake of nutrients was comparable
between the running groups and the control group, endurance
running was accompanied with reduced concentrations of
saturated fatty acids in RBC membranes (Kamada et al., 1993).
These results indicate that the RBC can adapt upon exposure
to exercise and that these adapted RBCs facilitate exercise and
proper delivery of oxygen to the tissues. Interestingly, Smith
et al. (1999) observed a higher maximal RBC deformability in
elite cyclists when compared with sedentary healthy controls.
Also, RBC populations with lower RBC densities were observed
in the elite cyclists, which could indicate increased RBC
turnover (Smith et al., 1999). A possible explanation for the
increased RBC deformability in elite cyclist could be that
extreme exercise leads to membrane loss and early RBC
uptake, which is likely to be compensated with relatively
young and good deformable RBCs. Whether increased RBC
deformability would lead to better sports performances is
unknown.
Autologous erythropoietin production is stimulated upon
exposure to high altitudes. Acute exposure to high altitude,
however, does not affect RBC deformability and RBC rheology
(Reinhart et al., 1991). The effects of chronic exposure to high
altitude seems largely unexplored. RBC deformability related
processes were investigated in RBC concentrates obtained from
Tibetans living at high altitude and from Tibetans at living at
lowland. RBC viscosity was increased, and RBCs were more
osmotic fragile in Tibetians living at low altitude when compared
to RBC concentrates obtained from their lowland residents
(Zhong et al., 2015). The increased viscosity can, however,
be affected by increased hemoglobin levels and the decreased
osmotic fragility can be affected by the decreased MCV values
in Tibetans living at high altitude. The effects of exercise under
hypoxia on RBC properties were investigated by Mao et al.
(2011). Exercise under hypoxic conditions was found to decrease
KCNN4 (or Gardos-channel) modulated deformability and
KCNN4 modulated volume and down-regulated the senescence
markers CD47 and CD147 (Mao et al., 2011). These results
indicate RBC dysfunction after exercise under hypoxia. The
dysfunction of RBCs under hypoxic conditions in combination
with the erythropoietin-driven increase in RBC production leads
to RBCs with relative low densities (Samaja et al., 1993), possibly
caused by both increased RBC turnover and increased RBC
production.
TABLE 2 | Summary of primary and secondary changes that lead to reduced RBC deformability in hereditary hemolytic anemia.
Anemia group Disorder Affected protein Secondary changes Deformability
Hemoglobinopathies Sickle cell anemia β globin High intracellular free Ca2+ dehydration
oxidation, hemolysis, NO scavenging,
KCNN4 (Gardos channel) activation,
different KCC activity
↓
Thalassemia Deficiency in α or β
globin chain
High intracellular free Ca2+ ↓
Metabolic disorders Pyruvate kinase
deficiency (PKD)
PK Changes in phosphorylate, low ATP,
low cAMP, AMPK activation,
intracellular free Ca2+ overload
↓, but dependent on technique
Hexokinase (HK)
deficiency
HK ↓, but dependent on technique
Glucose-6-phosphate-
dehydrogenase
G6PD AMPK activation when in hemolytic
crisis
Not affected, but ↓ when in crisis
Structural disorders Hereditary
Spherocytosis
Band 3, ankyrin,
SPTA1, SPTB, RhAG,
protein 4.1, protein 4.2
Increased MCHC, RBC vesiculation,
low intracellular K+
↓
Hereditary elliptocytosis SPTA1, SPTB or
protein 4.1
Formation of elliptocytes ↓
Channelopathies Hereditary xerocytosis PIEZO1 Low K+, RBC dehydration Slightly decreased, mainly dehydrated
Splenectomy contra-indicated
Gardos channelopathy Gardos channel Low intracellular K+, RBC dehydration,
increased Ca2+
Slightly decreased, mainly dehydrated
Reduced RBC deformability is noted in the table with ↓.
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SUMMARY
Deformability is an important parameter that regulates RBC
rheology, its longevity, and efficacy of O2 transport. Altered
deformability is a characteristic feature of multiple forms
of hereditary hemolytic anemias and is likely related to
the severity of the disease. Factors regulating deformability
at the cellular level are dehydration, membrane protein
phosphorylation, cytoskeletal integrity, metabolism and the
integrity of hemoglobin. Interaction of these factors makes
RBCs more or less deformable. Measuring RBC deformability in
research and diagnostic laboratories can be challenging as there
are many techniques available with all their specific advantages
and disadvantages.
Measuring RBC deformability is important from both a
diagnostic and research point of view. RBC deformability (i)
could provide information about the patient’s disease and
clinical severity, and (ii) could be a target for pharmacological
intervention or predict the toxicity of drugs for patients with
hemolytic anemias.
Reduced RBC deformability leads to an inability of the
RBC to pass the splenic circulation and leads to premature
removal of RBCs from the blood. Altered RBC deformability
can be attributed to primary and secondary changes of RBC
deformability. Primary changes of RBC deformability are directly
related to the disease, such as the membrane weakening in HS
or the formation of poorly deformable sickle cells in sickle cell
disease. Secondary changes of RBC deformability, such as altered
ion fluxes, aberrant membrane protein phosphorylation or RBC
vesiculation, are not directly related to the cause of disease.
Thus, both primary and secondary causes of RBC deformability
can contribute to premature uptake of RBCs in the spleen. In
this review and in Table 2, we have summarized the current
knowledge on primary and secondary mechanisms of RBC
deformability in sickle cell anemia, thalassemia, HS, hereditary
xerocytosis, and a number of metabolic disorders of the RBC.
We have addressed and discussed the effects of ion regulation,
ion channels and RBC (de)hydration on RBC deformability.
In addition, we discuss the role and current knowledge of
the adaptive responses on RBC deformability, intracellular
energy-sensing molecules, membrane protein phosphorylation,
hemoglobin deoxygenation and RBC vesiculation on RBC
deformability. Knowledge about these processes in the RBC
will lead to better understanding of the secondary processes
involved in premature removal, and could lead to the discovery
of new targets for pharmacological treatment. Furthermore, we
postulate that a number of currently undiagnosed, patients with
hereditary hemolytic anemia may have (genetic) defects in the
here discussed secondary pathways or secondary processes that
regulate RBC deformability. This review helps to understand
the molecular mechanisms that maintain RBC deformability in
healthy and diseased individuals, and enumerates the molecular
mechanisms that are altered in RBC disorders leading to
hereditary hemolytic anemia.
AUTHOR CONTRIBUTIONS
RvW, RS, and WvS encouraged RH to investigate the properties
of RBC deformability. RH and RvW wrote the manuscript with
support from RS, AB, LK, and WvS.
FUNDING
This research has received funding from the European Seventh
Framework Program under grant agreement number 602121
(CoMMiTMenT).
REFERENCES
Adderley, S. P., Sprague, R. S., Stephenson, A. H., and Hanson, M. S. (2010).
Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol. Rep.
62, 475–482. doi: 10.1016/s1734-1140(10)70303-0
Adderley, S. P., Thuet, K. M., Sridharan, M., Bowles, E. A., Stephenson, A. H.,
Ellsworth, M. L., et al. (2011). Identification of cytosolic phosphodiesterases in
the erythrocyte: a possible role for PDE5. Med. Sci. Monit. 17, CR241–CR247.
doi: 10.12659/msm.881763
Adragna, N. C., Di Fulvio, M., and Lauf, P. K. (2004). Regulation of K-Cl
cotransport: from function to genes. J. Membr. Biol. 201, 109–137. doi: 10.1007/
s00232-004-0695-6
Alaarg, A., Schiffelers, R. M., van Solinge, W. W., and van Wijk, R. (2013). Red
blood cell vesiculation in hereditary hemolytic anemia. Front. Physiol. 4:365.
doi: 10.3389/fphys.2013.00365
Alapan, Y., Little, J. A., and Gurkan, U. A. (2015). Heterogeneous red blood cell
adhesion and deformability in sickle cell disease. Sci. Rep. 4:7173. doi: 10.1038/
srep07173
Alapan, Y., Matsuyama, Y., Little, J. A., and Gurkan, U. A. (2016). Dynamic
deformability of sickle red blood cells in microphysiological flow. Technology
4, 71–79. doi: 10.1142/S2339547816400045
Albuisson, J., Murthy, S. E., Bandell, M., Coste, B., Louis-Dit-Picard, H., Mathur, J.,
et al. (2013). Dehydrated hereditary stomatocytosis linked to gain-of-function
mutations in mechanically activated PIEZO1 ion channels. Nat. Commun.
4:1884. doi: 10.1038/ncomms2899
Andolfo, I., Alper, S. L., De Franceschi, L., Auriemma, C., Russo, R., De Falco, L.,
et al. (2013). Multiple clinical forms of dehydrated hereditary stomatocytosis
arise from mutations in PIEZO1. Blood 121, S1–S12. doi: 10.1182/blood-2013-
02-482489
Andolfo, I., Russo, R., Manna, F., Shmukler, B. E., Gambale, A., Vitiello, G.,
et al. (2015). Novel Gardos channel mutations linked to dehydrated hereditary
stomatocytosis (xerocytosis). Am. J. Hematol. 90, 921–926. doi: 10.1002/ajh.
24117
Anong, W. A. (2006). Rate of rupture and reattachment of the band 3-ankyrin
bridge on the human erythrocyte membrane. J. Biol. Chem. 281, 22360–22366.
doi: 10.1074/jbc.M513839200
Ataga, K. I., Reid, M., Ballas, S. K., Yasin, Z., Bigelow, C., James, L. S., et al.
(2011). Improvements in haemolysis and indicators of erythrocyte survival do
not correlate with acute vaso-occlusive crises in patients with sickle cell disease:
a phase III randomized, placebo-controlled, double-blind study of the Gardos
channel blocker senicapo. Br. J. Haematol. 153, 92–104. doi: 10.1111/j.1365-
2141.2010.08520.x
Ataga, K. I., Smith, W. R., De Castro, L. M., Swerdlow, P., Saunthararajah, Y.,
Castro, O., et al. (2008). Efficacy and safety of the Gardos
channel blocker, senicapoc (ICA-17043), in patients with sickle
cell anemia. Blood 111, 3991–3997. doi: 10.1182/blood-2007-08-11
0098
Bae, C., Sachs, F., and Gottlieb, P. A. (2011). The mechanosensitive ion channel
Piezo1 is inhibited by the peptide GsMTx4. Biochemistry 50, 6295–6300.
doi: 10.1021/bi200770q
Frontiers in Physiology | www.frontiersin.org 16 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 17
Huisjes et al. Properties of RBC Deformability
Barodka, V., Mohanty, J. G., Mustafa, A. K., Santhanam, L., Nyhan, A., Bhunia,
A. K., et al. (2014). Nitroprusside inhibits calcium-induced impairment
of red blood cell deformability. Transfusion 54, 434–444. doi: 10.1111/trf.
12291
Beneteau, C., Thierry, G., Blesson, S., Le Vaillant, C., Picard, V., Béné, M. C., et al.
(2014). Recurrent mutation in the PIEZO1 gene in two families of hereditary
xerocytosis with fetal hydrops. Clin. Genet. 85, 293–295. doi: 10.1111/cge.12147
Bernhardt, I., Hall, A. C., and Ellory, J. C. (1988). Transport pathways for
monovalent cations through erythrocyte membranes. Stud. Biophys 126, 5–21.
Bevers, E. M., Wiedmer, T., Comfurius, P., Shattil, S. J., Weiss, H. J., Zwaal,
R. F., et al. (1992). Defective Ca2+-induced microvesiculation and deficient
expression of procoagulant activity in erythrocytes from a patient with a
bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 79,
380–388.
Bianchi, P., Fermo, E., Vercellati, C., Marcello, A. P., Porretti, L., Cortelezzi, A.,
et al. (2012). Diagnostic power of laboratory tests for hereditary spherocytosis:
a comparison study in 150 patients grouped according to molecular and clinical
characteristics. Haematologica 97, 516–523. doi: 10.3324/haematol.2011.052845
Biro, E., Sturk-Maquelin, K. N., Vogel, G. M. T., Meuleman, D. G., Smit, M. J.,
Hack, C. E., et al. (2003). Human cell-derived microparticles promote thrombus
formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost. 1,
2561–2568. doi: 10.1046/j.1538-7836.2003.00456.x
Bize, I., Taher, S., and Brugnara, C. (2003). Regulation of K-Cl cotransport
during reticulocyte maturation and erythrocyte aging in normal and sickle
erythrocytes. Am. J. Physiol. Cell Physiol. 285, C31–C38. doi: 10.1152/ajpcell.
00447.2002
Boas, F. E., Forman, L., and Beutler, E. (1998). Phosphatidylserine exposure and
red cell viability in red cell aging and in hemolytic anemia. Proc. Natl. Acad. Sci.
U.S.A. 95, 3077–3081. doi: 10.1073/pnas.95.6.3077
Bogdanova, A., Berenbrink, M., and Nikinmaa, M. (2009). Oxygen-dependent ion
transport in erythrocytes. Acta Physiol. 195, 305–319. doi: 10.1111/j.1748-1716.
2008.01934.x
Bogdanova, A., Makhro, A., Seiler, E., Max Gass, A., Hegemann, I., and Muller, R.
(2017). “N-methyl D-glutamate receptor as a pharmacological target for
treatment of sickle cell disease: effect of memantine on red cells of patients on
a pilot clinical trail MemSID,” in Proceedings of the 21th Meeting of the Red Cell
Society, Heidelberg.
Bogdanova, A., Makhro, A., Wang, J., Lipp, P., and Kaestner, L. (2013). Calcium in
red blood cells-a perilous balance. Int. J. Mol. Sci. 14, 9848–9872. doi: 10.3390/
ijms14059848
Bogdanova, A., Petrushanko, I. Y., Hernansanz-Agustín, P., and Martínez-Ruiz, A.
(2016). “Oxygen Sensing” by Na,K-ATPase: these miraculous thiols. Front.
Physiol. 7:314. doi: 10.3389/fphys.2016.00314
Bookchin, R. M., and Lew, V. L. (1980). Progressive inhibition of the Ca pump and
Ca:Ca exchange in sickle red cells. Nature 284, 561–563. doi: 10.1038/284561a0
Bookchin, R. M., Ortiz, O. E., Shalev, O., Tsurel, S., Rachmilewitz, E. A.,
Hockaday, A., et al. (1988). Calcium transport and ultrastructure of red cells
in beta-thalassemia intermedia. Blood 72, 1602–1607.
Bordin, L., Clari, G., Moro, I., Dalla Vecchia, F., and Moret, V. (1995). Functional
link between phosphorylation state of membrane proteins and morphological
changes of human erythrocytes. Biochem. Biophys. Res. Commun. 213, 249–257.
doi: 10.1006/bbrc.1995.2123
Bosch, F. H., Werre, J. M., Schipper, L., Roerdinkholder-Stoelwinder, B., Huls, T.,
Willekens, F. L., et al. (1994). Determinants of red blood cell deformability in
relation to cell age. Eur. J. Haematol. 52, 35–41. doi: 10.1111/j.1600-0609.1994.
tb01282.x
Bosman, G. J. (2013). Survival of red blood cells after transfusion: processes and
consequences. Front. Physiol. 4:376. doi: 10.3389/fphys.2013.00376
Bouyer, G., Thomas, S., and Ege, S. (2012). Patch-Clamp Analysis of
Membrane Transport in Erythrocytes, Patch Clamp Technique. Available
at: https://www.intechopen.com/books/patch-clamp-technique/patch-clamp-
analysis-of-membrane-transport-in-erythrocytes
Brugnara, C. (1993). Membrane transport of Na and K and cell dehydration in
sickle erythrocytes. Experientia 49, 100–109. doi: 10.1007/bf01989413
Brugnara, C., and Mohandas, N. (2013). Red cell indices in classification and
treatment of anemias: from M.M. Wintrobes’s original 1934 classification to
the third millennium. Curr. Opin. Hematol. 20, 222–230. doi: 10.1097/MOH.
0b013e32835f5933
Bunn, H. F. (1997). Pathogenesis and treatment of sickle cell disease. N. Engl. J.
Med. 337, 762–769. doi: 10.1056/NEJM199709113371107
Bunyaratvej, A., Fucharoen, S., Greenbaum, A., and Mohandas, N. (1994).
Hydration of red cells in alpha and beta thalassemias differs. A useful approach
to distinguish between these red cell phenotypes. Am. J. Clin. Pathol. 102,
217–222. doi: 10.1093/ajcp/102.2.217
Burger, P., Hilarius-Stokman, P., de Korte, D., van den Berg, T. K., and van
Bruggen, R. (2012). CD47 functions as a molecular switch for erythrocyte
phagocytosis. Blood 119, 5512–5521. doi: 10.1182/blood-2011-10-386805
Burton, N. M., and Bruce, L. J. (2011). Modelling the structure of the red cell
membrane. Biochem. Cell Biol. 89, 200–215. doi: 10.1139/o10-154
Bütikofer, P., Lin, Z. W., Kuypers, F. A., Scott, M. D., Xu, C. M., Wagner, G. M.,
et al. (1989). Chlorpromazine inhibits vesiculation, alters phosphoinositide
turnover and changes deformability of ATP-depleted RBCs. Blood 73,
1699–1704. doi: 10.1128/EC.00038-15
Cahalan, S. M., Lukacs, V., Ranade, S. S., Chien, S., Bandell, M., and Patapoutian, A.
(2015). Piezo1 links mechanical forces to red blood cell volume. eLife 4:e07370.
doi: 10.7554/eLife.07370
Cai, M., Zhao, W., Shang, X., Jiang, J., Ji, H., Tang, Z., et al. (2012). Direct
evidence of lipid rafts by in situ atomic force microscopy. Small 8, 1243–1250.
doi: 10.1002/smll.201102183
Cappellini, M. D., and Fiorelli, G. (2008). Glucose-6-phosphate dehydrogenase
deficiency. Lancet 371, 64–74. doi: 10.1016/S0140-6736(08)60073-2
Carlson, D. L., and Mawdsley, R. H. (1986). Sports anemia: a review of the
literature. Am. J. Sports Med. 14, 109–112. doi: 10.1177/036354658601400202
Chabanel, A., Reinhart, W., and Chien, S. (1987). Increased resistance to
membrane deformation of shape-transformed human red blood cells. Blood 69,
739–743.
Chétrite, G., and Cassoly, R. (1985). Affinity of hemoglobin for the cytoplasmic
fragment of human erythrocyte membrane band 3. Equilibrium measurements
at physiological pH using matrix-bound proteins: the effects of ionic strength,
deoxygenation and of 2,3-diphosphoglycerate. J. Mol. Biol. 185, 639–644.
doi: 10.1016/0022-2836(85)90076-2
Chu, H., Puchulu-Campanella, E., Galan, J. A., Tao, W. A., Low, P. S., and Hoffman,
J. F. (2012). Identification of cytoskeletal elements enclosing the ATP pools that
fuel human red blood cell membrane cation pumps. Proc. Natl. Acad. Sci. U.S.A.
109, 12794–12799. doi: 10.1073/pnas.1209014109
Chui, D. H., Fucharoen, S., and Chan, V. (2003). Hemoglobin H disease: not
necessarily a benign disorder. Blood 101, 791–800. doi: 10.1182/blood-2002-
07-1975
Ciana, A., Achilli, C., Gaur, A., and Minetti, G. (2017). Membrane remodelling and
vesicle formation during ageing of human red blood cells. Cell. Physiol. Biochem.
42, 1127–1138. doi: 10.1159/000478768
Cinar, E., Zhou, S., DeCourcey, J., Wang, Y., Waugh, R. E., and Wan, J. (2015).
Piezo1 regulates mechanotransductive release of ATP from human RBCs. Proc.
Natl. Acad. Sci. U.S.A. 112, 11783–11788. doi: 10.1073/pnas.1507309112
Cividalli, G., Locker, H., and Russell, A. (1971). Increased permeability of
erythrocyte membrane in thalassemia. Blood 37, 716–724.
Clark, M. R., Mohandas, N., and Shohet, S. B. (1982). Hydration of sickle cells
using the sodium ionophore Monensin. A model for therapy. J. Clin. Invest.
70, 1074–1080. doi: 10.1172/jci110695
Clark, M. R., Mohandas, N., and Shohet, S. B. (1983). Osmotic gradient
ektacytometry: comprehensive characterization of red cell volume and surface
maintenance. Blood 61, 899–910.
Cluitmans, J. C. A., Chokkalingam, V., Janssen, A. M., Brock, R., Huck, W. T. S.,
and Bosman, G. J. C. G. M. (2014). Alterations in red blood cell deformability
during storage: a microfluidic approach. Biomed Res. Int. 2014:764268.
doi: 10.1155/2014/764268
Condon, M. R., Feketova, E., Machiedo, G. W., Deitch, E. A., and Spolarics, Z.
(2007). Augmented erythrocyte band-3 phosphorylation in septic mice.
Biochim. Biophys. Acta 1772, 580–586. doi: 10.1016/j.bbadis.2007.02.004
Crable, S. C., Hammond, S. M., Papes, R., Rettig, R. K., Zhou, G.-P., Gallagher,
P. G., et al. (2005). Multiple isoforms of the KC1 cotransporter are expressed
in sickle and normal erythroid cells. Exp. Hematol. 33, 624–631. doi: 10.1016/j.
exphem.2005.02.006
Da Costa, L., Galimand, J., Fenneteau, O., and Mohandas, N. (2013). Hereditary
spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev.
27, 167–178. doi: 10.1016/j.blre.2013.04.003
Frontiers in Physiology | www.frontiersin.org 17 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 18
Huisjes et al. Properties of RBC Deformability
Da Costa, L., Suner, L., Galimand, J., Bonnel, A., Pascreau, T., Couque, N., et al.
(2016). Diagnostic tool for red blood cell membrane disorders: assessment of
a new generation ektacytometer. Blood Cells Mol. Dis. 56, 9–22. doi: 10.1016/j.
bcmd.2015.09.001
Danielczok, J. G., Terriac, E., Hertz, L., Petkova-Kirova, P., Lautenschläger, F.,
Laschke, M. W., et al. (2017). Red blood cell passage of small capillaries is
associated with transient Ca2+-mediated adaptations. Front. Physiol. 8:979.
doi: 10.3389/fphys.2017.00979
de Back, D. Z., Kostova, E. B., van Kraaij, M., van den Berg, T. K., and van
Bruggen, R. (2014). Of macrophages and red blood cells; a complex love story.
Front. Physiol. 5:9. doi: 10.3389/fphys.2014.00009
De Franceschi, L., Cappellini, M. D., Graziadei, G., Manzato, F., Olivieri, O.,
Corrocher, R., et al. (1998). The effect of dietary magnesium supplementation
on the cellular abnormalities of erythrocytes in patients with beta thalassemia
intermedia. Haematologica 83, 118–125.
De Franceschi, L., Olivieri, O., Miraglia del Giudice, E., Perrotta, S., Sabato, V.,
Corrocher, R., et al. (1997). Membrane cation and anion transport activities in
erythrocytes of hereditary spherocytosis: effects of different membrane protein
defects. Am. J. Hematol. 55, 121–128. doi: 10.1002/(SICI)1096-8652(199707)55:
3<121::AID-AJH1>3.0.CO;2-U
De Franceschi, L., Rivera, A., Fleming, M. D., Honczarenko, M., Peters, L. L.,
Gascard, P., et al. (2005). Evidence for a protective role of the Gardos channel
against hemolysis in murine spherocytosis. Blood 106, 1454–1459. doi: 10.1182/
blood-2005-01-0368
de Franceschi, L., Rouyer-Fessard, P., Alper, S. L., Jouault, H., Brugnara, C., and
Beuzard, Y. (1996). Combination therapy of erythropoietin, hydroxyurea, and
clotrimazole in a beta thalassemic mouse: a model for human therapy. Blood 87,
1188–1195.
Deplaine, G., Safeukui, I., Jeddi, F., Lacoste, F., Brousse, V., Perrot, S., et al. (2010).
The sensing of poorly deformable red blood cells by the human spleen can be
mimicked in vitro. Blood 117, e88–e95. doi: 10.1182/blood-2010-10-312801
Derbyshire, E. R., and Marletta, M. A. (2012). Structure and regulation of soluble
guanylate cyclase. Annu. Rev. Biochem. 81, 533–559. doi: 10.1146/annurev-
biochem-050410-100030
Dobbe, J. G., Streekstra, G. J., Hardeman, M. R., Ince, C., and Grimbergen, C. A.
(2002). Measurement of the distribution of red blood cell deformability using
an automated rheoscope. Cytometry 50, 313–325. doi: 10.1002/cyto.10171
Eaton, W. A., and Hofrichter, J. (1990). Sickle cell hemoglobin polymerization. Adv.
Protein Chem. 40, 63–279. doi: 10.1016/S0065-3233(08)60287-9
Eisinger, J., Flores, J., and Salhany, J. M. (1982). Association of cytosol hemoglobin
with the membrane in intact erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 79,
408–412. doi: 10.1073/pnas.79.2.408
Faucherre, A., Kissa, K., Nargeot, J., Mangoni, M. E., and Jopling, C. (2014). Piezo1
plays a role in erythrocyte volume homeostasis. Haematologica 99, 70–75.
doi: 10.3324/haematol.2013.086090
Fens, M. H., van Wijk, R., Andringa, G., van Rooijen, K. L., Dijstelbloem, H. M.,
Rasmussen, J. T., et al. (2012). A role for activated endothelial cells in red blood
cell clearance: implications for vasopathology. Haematologica 97, 500–508.
doi: 10.3324/haematol.2011.048694
Fermo, E., Bogdanova, A., Petkova-Kirova, P., Zaninoni, A., Marcello, A. P.,
Makhro, A., et al. (2017a). “Gardos Channelopathy”: a variant of hereditary
Stomatocytosis with complex molecular regulation. Sci. Rep. 7:1744.
doi: 10.1038/s41598-017-01591-w
Fermo, E., Vercellati, C., Marcello, A. P., Zaninoni, A., van Wijk, R., Mirra, N., et al.
(2017b). Hereditary xerocytosis due to mutations in PIEZO1 gene associated
with heterozygous pyruvate kinase deficiency and beta-thalassemia trait in
two unrelated families. Case Rep. Hematol. 2017:2769570. doi: 10.1155/2017/
2769570
Fischer, D. J., Torrence, N. J., Sprung, R. J., and Spence, D. M. (2003).
Determination of erythrocyte deformability and its correlation to cellular ATP
release using microbore tubing with diameters that approximate resistance
vessels in vivo. Analyst 128, 1163–1168. doi: 10.1039/b308225n
Föller, M., Sopjani, M., Koka, S., Gu, S., Mahmud, H., Wang, K., et al. (2009).
Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J.
23, 1072–1080. doi: 10.1096/fj.08-121772
Foretz, M., Guihard, S., Leclerc, J., Fauveau, V., Couty, J.-P., Andris, F., et al. (2010).
Maintenance of red blood cell integrity by AMP-activated protein kinase alpha1
catalytic subunit. FEBS Lett. 584, 3667–3671. doi: 10.1016/j.febslet.2010.07.041
Gadsby, D. C. (2009). Ion channels versus ion pumps: the principal difference, in
principle. Nat. Rev. Mol. Cell Biol. 10, 344–352. doi: 10.1038/nrm2668
Galanello, R., and Origa, R. (2010). Beta-thalassemia. Orphanet J. Rare Dis. 5, 11.
doi: 10.1186/1750-1172-5-11
Gallagher, P. G. (2004a). Hereditary elliptocytosis: spectrin and protein 4.1R.
Semin. Hematol. 41, 142–164. doi: 10.1053/j.seminhematol.2004.01.003
Gallagher, P. G. (2004b). Update on the clinical spectrum and genetics of red blood
cell membrane disorders. Curr. Hematol. Rep. 3, 85–91.
Gallagher, P. G. (2013). Disorders of red cell volume regulation. Curr. Opin.
Hematol. 20, 201–207. doi: 10.1097/MOH.0b013e32835f6870
Gallagher, P. G. (2017). Disorders of erythrocyte hydration. Blood 130, 2699–2708.
doi: 10.1182/blood-2017-04-590810
Ge, J., Li, W., Zhao, Q., Li, N., Chen, M., Zhi, P., et al. (2015). Architecture
of the mammalian mechanosensitive Piezo1 channel. Nature 527, 64–69.
doi: 10.1038/nature15247
George, A., Pushkaran, S., Li, L., An, X., Zheng, Y., Mohandas, N., et al. (2010).
Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the
role of protein kinase C. Rac GTPases, and reactive oxygen species. Blood Cells
Mol. Dis. 45, 41–45. doi: 10.1016/j.bcmd.2010.02.006
Gibson, J. S., Cossins, A. R., and Ellory, J. C. (2000). Oxygen-sensitive membrane
transporters in vertebrate red cells. J. Exp. Biol. 203, 1395–1407.
Gibson, J. S., Khan, A., Speake, P. F., and Ellory, J. C. (2001). O2 dependence
of K+ transport in sickle cells: the effect of different cell populations and
the substituted benzaldehyde 12C79. FASEB J. 15, 823–832. doi: 10.1096/fj.00-
0177com
Gibson, J. S., Speake, P. F., and Ellory, J. C. (1998). Differential oxygen sensitivity of
the K+-Cl- cotransporter in normal and sickle human red blood cells. J. Physiol.
511(Pt 1), 225–234. doi: 10.1111/j.1469-7793.1998.225bi.x
Glogowska, E., Lezon-Geyda, K., Maksimova, Y., Schulz, V. P., and Gallagher,
P. G. (2015). Mutations in the Gardos channel (KCNN4) are associated with
hereditary xerocytosis. Blood 126, 1281–1284. doi: 10.1182/blood-2015-07-
657957
Glogowska, E., Schneider, E. R., Maksimova, Y., Schulz, V. P., Lezon-Geyda, K.,
Wu, J., et al. (2017). Novel mechanisms of PIEZO1 dysfunction in hereditary
xerocytosis. Blood 130, 1845–1856. doi: 10.1182/blood-2017-05-786004
Goldstein, L., and Brill, S. R. (1991). Volume-activated taurine eﬄux from skate
erythrocytes: possible band 3 involvement. Am. J. Physiol. 260, R1014–R1020.
doi: 10.1152/ajpregu.1991.260.5.R1014
Goldstein, L., and Davis, E. M. (1994). Taurine, betaine, and inositol share a
volume-sensitive transporter in skate erythrocyte cell membrane. Am. J. Physiol.
267, R426–R431. doi: 10.1152/ajpregu.1994.267.2.R426
Grau, M., Pauly, S., Ali, J., Walpurgis, K., Thevis, M., Bloch, W., et al. (2013).
RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC
deformability. PLoS One 8:e56759. doi: 10.1371/journal.pone.0056759
Greenwalt, T. J., and Dumaswala, U. J. (1988). Effect of red cell age on vesiculation
in vitro. Br. J. Haematol. 68, 465–467. doi: 10.1111/j.1365-2141.1988.tb04237.x
Guo, Q., Duffy, S. P., Matthews, K., Santoso, A. T., Scott, M. D., and Ma, H. (2014).
Microfluidic analysis of red blood cell deformability. J. Biomech. 47, 1767–1776.
doi: 10.1016/j.jbiomech.2014.03.038
Hagley, A. C., Younger-Coleman, N. O., Richards, A. A., Nwokocha, C. R., and
Pepple, D. J. (2011). The effect of sildenafil on the elasticity of erythrocytes in
homozygous sickle cell disease. Indian J. Med. Sci. 65, 243–249. doi: 10.4103/
0019-5359.107024
Hahn, E. V., and Gillespie, E. B. (1927). Sickle cell anemia. Arch. Intern. Med. 39,
233–254. doi: 10.1001/archinte.1927.00130020072006
Hänggi, P., Makhro, A., Gassmann, M., Schmugge, M., Goede, J. S., Speer, O.,
et al. (2014). Red blood cells of sickle cell disease patients exhibit abnormally
high abundance of N-methyl D-aspartate receptors mediating excessive calcium
uptake. Br. J. Haematol. 167, 252–264. doi: 10.1111/bjh.13028
Hardeman, M. R., Goedhart, P., and Breederveld, D. (1987). Laser diffraction
ellipsometry of erythrocytes under controlled shear stress using a rotational
viscosimeter. Clin. Chim. Acta 165, 227–234. doi: 10.1016/0009-8981(87)
90166-5
Harrison, T., Samuel, B. U., Akompong, T., Hamm, H., Mohandas, N., Lomasney,
J. W., et al. (2003). Erythrocyte G protein-coupled receptor signaling in malarial
infection. Science 301, 1734–1736. doi: 10.1126/science.1089324
Harteveld, C. L., and Higgs, D. R. (2010). Alpha-thalassaemia. Orphanet J. Rare Dis.
5:13. doi: 10.1186/1750-1172-5-13
Frontiers in Physiology | www.frontiersin.org 18 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 19
Huisjes et al. Properties of RBC Deformability
Hasegawa, S., Rodgers, G. P., Shio, H., Schechter, A. N., and Uyesaka, N. (1993).
Impaired deformability of Heinz body-forming red cells. Biorheology 30,
275–286. doi: 10.3233/BIR-1993-303-412
Hertz, L., Huisjes, R., Llaudet-Planas, E., Petkova-Kirova, P., Makhro, A.,
Danielczok, J. G., et al. (2017). Is increased intracellular calcium in red blood
cells a common component in the molecular mechanism causing anemia?
Front. Physiol. 8:673. doi: 10.3389/FPHYS.2017.00673
Higgs, D. R., Engel, J. D., and Stamatoyannopoulos, G. (2012). Thalassaemia.
Lancet 379, 373–383. doi: 10.1016/S0140-6736(11)60283-3
Huisjes, R., Petkova-Kirova, P., Makhro, A., Llaudet-Planas, E., Hertz, L.,
Verhagen, L., et al. (2017a). “In-depth characterization of the red blood cell
in hereditary spherocytosis,” in Proceedings of the 21th Meeting of the Red Cell
Society, Heidelberg.
Huisjes, R., van Solinge, W. W., Levin, M. D., van Wijk, R., and Riedl, J. A. (2017b).
Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic
anemia. Int. J. Lab. Hematol. 40, 159–168. doi: 10.1111/ijlh.12758
Hurley, R. L., Barré, L. K., Wood, S. D., Anderson, K. A., Kemp, B. E., Means,
A. R., et al. (2006). Regulation of AMP-activated protein kinase by multisite
phosphorylation in response to agents that elevate cellular cAMP. J. Biol. Chem.
281, 36662–36672. doi: 10.1074/jbc.M606676200
Iolascon, A., Andolfo, I., Barcellini, W., Corcione, F., Garçon, L., De Franceschi, L.,
et al. (2017). Recommendations regarding splenectomy in hereditary hemolytic
anemias. Haematologica 102, 1304–1313. doi: 10.3324/haematol.2016.16
1166
Izumo, H., Lear, S., Williams, M., Rosa, R., and Epstein, F. H. (1987). Sodium-
potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia.
J. Clin. Invest. 79, 1621–1628. doi: 10.1172/JCI112998
Jacques-Fricke, B. T., Seow, Y., Gottlieb, P. A., Sachs, F., and Gomez, T. M. (2006).
Ca2+ influx through mechanosensitive channels inhibits neurite outgrowth
in opposition to other influx pathways and release from intracellular stores.
J. Neurosci. 26, 5656–5664. doi: 10.1523/JNEUROSCI.0675-06.2006
Jaïs, X., Till, S. J., Cynober, T., Ioos, V., Garcia, G., Tchernia, G., et al.
(2003). An extreme consequence of splenectomy in dehydrated hereditary
stomatocytosis: gradual thrombo-embolic pulmonary hypertension and lung-
heart transplantation. Hemoglobin 27, 139–147. doi: 10.1081/HEM-12002
3377
Jordan, J., Kiernan, W., Merker, H., Wenzel, M., and Beneke, R. (1998). Red cell
membrane skeletal changes in marathon runners. Int. J. Sports Med. 19, 16–19.
doi: 10.1055/s-2007-971873
Kaestner, L. (2011) Cation Channels in Erythrocytes - Historical and Future
Perspective. Open Biol. J. 4, 27–34.
Kaestner, L. (2015). Channelizing the red blood cell: molecular biology competes
with patch-clamp. Front. Mol. Biosci. 2:46. doi: 10.3389/fmolb.2015.00046
Kaestner, L., Steffen, P., Nguyen, D. B., Wang, J., Wagner-Britz, L., Jung, A.,
et al. (2012). Lysophosphatidic acid induced red blood cell aggregation
in vitro. Bioelectrochemistry 87, 89–95. doi: 10.1016/j.bioelechem.2011.
08.004
Kaestner, L., Wang, X., Hertz, L., and Bernhardt, I. (2018). Voltage-activated ion
channels in non-excitable cells — a viewpoint regarding their physiological
justification. Front Physiol. 9:450. doi: 10.3389/fphys.2018.00450
Kamada, T., Tokuda, S., Aozaki, S., and Otsuji, S. (1993). Higher levels of
erythrocyte membrane fluidity in sprinters and long-distance runners. J. Appl.
Physiol. 74, 354–358. doi: 10.1152/jappl.1993.74.1.354
Kanno, H., Morimoto, M., Fujii, H., Tsujimura, T., Asai, H., Noguchi, T., et al.
(1995). Primary structure of murine red blood cell-type pyruvate kinase (PK)
and molecular characterization of PK deficiency identified in the CBA strain.
Blood 86, 3205–3210.
Karger, R., Lukow, C., and Kretschmer, V. (2012). Deformability of red blood cells
and correlation with ATP content during storage as leukocyte-depleted whole
blood. Transfus. Med. Hemother. 39, 277–282. doi: 10.1159/000339809
Kato, G. J., Steinberg, M. H., and Gladwin, M. T. (2017). Intravascular hemolysis
and the pathophysiology of sickle cell disease. J. Clin. Invest. 127, 750–760.
doi: 10.1172/JCI89741
Kay, M. M. (1984). Localization of senescent cell antigen on band 3. Proc. Natl.
Acad. Sci. U.S.A. 81, 5753–5757. doi: 10.1073/pnas.81.18.5753
Kay, M. M., Goodman, S. R., Sorensen, K., Whitfield, C. F., Wong, P., Zaki, L., et al.
(1983). Senescent cell antigen is immunologically related to band 3. Proc. Natl.
Acad. Sci. U.S.A. 80, 1631–1635. doi: 10.1073/pnas.80.6.1631
Kenney, H. W., Smoot, R. T., Trader, J. D., Dowe, C. R., Allain, C. C., and Campbell,
T. M. (1961). The sickle cell disease: current status and preliminary research
observations. J. Natl. Med. Assoc. 53, 137–143.
Khan, A. I., Drew, C., Ball, S. E., Ball, V., Ellory, J. C., and Gibson, J. S. (2004).
Oxygen dependence of K+-Cl− cotransport in human red cell ghosts and sickle
cells. Bioelectrochemistry 62, 141–146. doi: 10.1016/j.bioelechem.2003.07.005
Klarl, B. A., Lang, P. A., Kempe, D. S., Niemoeller, O. M., Akel, A., Sobiesiak, M.,
et al. (2006). Protein kinase C mediates erythrocyte “programmed cell death”
following glucose depletion. Am. J. Physiol. Cell Physiol. 290, C244–C253.
doi: 10.1152/ajpcell.00283.2005
Knebel, S. M., Elrick, M. M., Bowles, E. A., Zdanovec, A. K., Stephenson, A. H.,
Ellsworth, M. L., et al. (2013). Synergistic effects of prostacyclin analogs and
phosphodiesterase inhibitors on cyclic adenosine 3′,5′ monophosphate
accumulation and adenosine 3′5′ triphosphate release from human
erythrocytes. Exp. Biol. Med. 238, 1069–1074. doi: 10.1177/1535370213498981
Koralkova, P., van Solinge, W. W., and van Wijk, R. (2014). Rare hereditary red
blood cell enzymopathies associated with hemolytic anemia - pathophysiology,
clinical aspects, and laboratory diagnosis. Int. J. Lab. Hematol. 36, 388–397.
doi: 10.1111/ijlh.12223
Körmöczi, G. F., Säemann, M. D., Buchta, C., Peck-Radosavljevic, M., Mayr, W. R.,
Schwartz, D. W. M., et al. (2006). Influence of clinical factors on the haemolysis
marker haptoglobin. Eur. J. Clin. Invest. 36, 202–209. doi: 10.1111/j.1365-2362.
2006.01617.x
Kostova, E. B., Beuger, B. M., Klei, T. R. L., Halonen, P., Lieftink, C.,
Beijersbergen, R., et al. (2015). Identification of signalling cascades involved in
red blood cell shrinkage and vesiculation. Biosci. Rep. 35:e00187. doi: 10.1042/
BSR20150019
Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C.,
et al. (2017). Red blood cell function and dysfunction: redox regulation, nitric
oxide metabolism, anemia. . Antioxid. Redox Signal. 26, 718–742. doi: 10.1089/
ars.2016.6954
Lasch, J., Küllertz, G., and Opalka, J. R. (2000). Separation of erythrocytes into age-
related fractions by density or size? Counterflow centrifugation. Clin. Chem.
Lab. Med. 38, 629–632. doi: 10.1515/CCLM.2000.092
Lazarova, E., Gulbis, B., Oirschot, B., and van Wijk, R. (2017). Next-generation
osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis:
interlaboratory method validation and experience. Clin. Chem. Lab. Med. 55,
394–402. doi: 10.1515/cclm-2016-0290
Leblond, P. F., Coulombe, L., and Lyonnais, J. (1978). Erythrocyte populations
in pyruvate kinase deficiency anaemia following splenectomy. II. Cell
deformability. Br. J. Haematol. 39, 63–70. doi: 10.1111/j.1365-2141.1978.
tb07128.x
Leonard, C., Conrard, L., Guthmann, M., Pollet, H., Carquin, M., Vermylen, C.,
et al. (2017). Contribution of plasma membrane lipid domains to red blood cell
(re)shaping. Sci. Rep. 7:4264. doi: 10.1038/s41598-017-04388-z
Lew, V. L., and Bookchin, R. M. (2005). Ion transport pathology in the mechanism
of sickle cell dehydration. Physiol. Rev. 85, 179–200. doi: 10.1152/physrev.
00052.2003
Lew, V. L., and Tiffert, T. (2017). On the mechanism of human red blood cell
longevity: roles of calcium, the sodium pump, PIEZO1 and Gardos channels.
Front. Physiol. 8:977. doi: 10.3389/FPHYS.2017.00977
Li, J., Hou, B., Tumova, S., Muraki, K., Bruns, A., Ludlow, M. J., et al. (2014).
Piezo1 integration of vascular architecture with physiological force. Nature 515,
279–282. doi: 10.1038/nature13701
Linderkamp, O., Friederichs, E., Boehler, T., and Ludwig, A. (1993). Age
dependency of red blood cell deformability and density: studies in transient
erythroblastopenia of childhood. Br. J. Haematol. 83, 125–129. doi: 10.1111/j.
1365-2141.1993.tb04642.x
Liu, L., Lei, T., Bankir, L., Zhao, D., Gai, X., Zhao, X., et al. (2011). Erythrocyte
permeability to urea and water: comparative study in rodents, ruminants,
carnivores, humans, and birds. J. Comp. Physiol. B 181, 65–72. doi: 10.1007/
s00360-010-0515-5
Livaja Koshiar, R., Somajo, S., Norström, E., Dahlbäck, B., and McMahon, C.
(2014). Erythrocyte-derived microparticles supporting activated protein
C-mediated regulation of blood coagulation. PLoS One 9:e104200. doi: 10.1371/
journal.pone.0104200
Llaudet-Planas, E., Vives-Corrons, J. L., Rizzuto, V., Gómez-Ramírez, P., Sevilla
Navarro, J., Coll Sibina, M. T., et al. (2017). Osmotic gradient ektacytometry:
Frontiers in Physiology | www.frontiersin.org 19 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 20
Huisjes et al. Properties of RBC Deformability
a valuable screening test for hereditary spherocytosis and other red blood cell
membrane disorders. Int. J. Lab. Hematol. 40, 94–102. doi: 10.1111/ijlh.12746
Locovei, S., Bao, L., and Dahl, G. (2006). Pannexin 1 in erythrocytes: function
without a gap. Proc. Natl. Acad. Sci. U.S.A. 103, 7655–7659. doi: 10.1073/pnas.
0601037103
Longley, D. B., Harkin, D. P., and Johnston, P. G. (2003). 5-fluorouracil:
mechanisms of action and clinical strategies. Nat. Rev. Cancer 3, 330–338.
doi: 10.1038/nrc1074
Lopes de Almeida, J. P., Freitas-Santos, T., and Saldanha, C. (2012). Erythrocyte
deformability dependence on band 3 protein in an in-vitro model of
hyperfibrinogenemia. Clin. Hemorheol. Microcirc. 50, 213–219. doi: 10.3233/
CH-2010-1433
Losco, P., Nash, G., Stone, P., and Ventre, J. (2001). Comparison of the effects of
radiographic contrast media on dehydration and filterability of red blood cells
from donors homozygous for hemoglobin A or hemoglobin S. Am. J. Hematol.
68, 149–158. doi: 10.1002/ajh.1171
Lubin, A., and Desforges, J. F. (1972). Effect of Heinz bodies on red cell
deformability. Blood 39, 658–665.
Lutz, H. U., Stammler, P., Fasler, S., Ingold, M., and Fehr, J. (1992). Density
separation of human red blood cells on self forming Percoll gradients:
correlation with cell age. Biochim. Biophys. Acta 1116, 1–10. doi: 10.1016/0304-
4165(92)90120-J
Ma, Y.-L., Rees, D. C., Gibson, J. S., and Ellory, J. C. (2012). The conductance of
red blood cells from sickle cell patients: ion selectivity and inhibitors. J. Physiol.
590, 2095–2105. doi: 10.1113/jphysiol.2012.229609
MacDonald, I. C., Ragan, D. M., Schmidt, E. E., and Groom, A. C. (1987). Kinetics
of red blood cell passage through interendothelial slits into venous sinuses
in rat spleen, analyzed by in vivo microscopy. Microvasc. Res. 33, 118–134.
doi: 10.1016/0026-2862(87)90011-2
Mairbäurl, H. (2013). Red blood cells in sports: effects of exercise and training on
oxygen supply by red blood cells. Front. Physiol. 4:332. doi: 10.3389/fphys.2013.
00332
Makhro, A., Huisjes, R., Verhagen, L. P., Mañú-Pereira, M., Llaudet-Planas, E.,
Petkova-Kirova, P., et al. (2016). Red cell properties after different modes of
blood transportation. Front. Physiol. 7:288. doi: 10.3389/fphys.2016.00288
Mangat, C., Inoue, S., Saah, E., and Sharman, M. (2014). Acute haemolytic anaemia
and myolysis due to G6PD deficiency. BMJ Case Rep. 2014:bcr2014203631.
doi: 10.1136/bcr-2014-203631
Mao, T.-Y., Fu, L.-L., and Wang, J.-S. (2011). Hypoxic exercise training causes
erythrocyte senescence and rheological dysfunction by depressed Gardos
channel activity. J. Appl. Physiol. 111, 382–391. doi: 10.1152/japplphysiol.00096.
2011
Marie, J., Buc, H., Simon, M. P., and Kahn, A. (1980). Phosphorylation of human
erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases.
Comparison with human liver L-type enzyme. Eur. J. Biochem. 108, 251–260.
doi: 10.1111/j.1432-1033.1980.tb04718.x
Marques, F., Crespo, M. E., Silva, Z. I., and Bicho, M. (2000). Insulin and high
glucose modulation of phosphatase and reductase enzymes in the human
erythrocytes: a comparative analysis in normal and diabetic states. Diabetes Res.
Clin. Pract. 47, 191–198. doi: 10.1016/S0168-8227(99)00128-X
Martinov, M. V., Plotnikov, A. G., Vitvitsky, V. M., and Ataullakhanov, F. I. (2000).
Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia.
Biochim. Biophys. Acta 1474, 75–87. doi: 10.1016/S0304-4165(99)00218-4
McNaughton-Smith, G. A., Burns, J. F., Stocker, J. W., Rigdon, G. C., Creech, C.,
Arrington, S., et al. (2008). Novel inhibitors of the Gardos channel for the
treatment of sickle cell disease. J. Med. Chem. 51, 976–982. doi: 10.1021/
jm070663s
Mebius, R. E., and Kraal, G. (2005). Structure and function of the spleen. Nat. Rev.
Immunol. 5, 606–616. doi: 10.1038/nri1669
Mihaylova, M. M., and Shaw, R. J. (2011). The AMPK signalling pathway
coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 13,
1016–1023. doi: 10.1038/ncb2329
Minetti, G., Egée, S., Mörsdorf, D., Steffen, P., Makhro, A., Achilli, C., et al. (2013).
Red cell investigations: art and artefacts. Blood Rev. 27, 91–101. doi: 10.1016/j.
blre.2013.02.002
Moriyama, R., Lombardo, C. R., Workman, R. F., and Low, P. S. (1993).
Regulation of linkages between the erythrocyte membrane and its skeleton by
2,3-diphosphoglycerate. J. Biol. Chem. 268, 10990–10996.
Muravyov, A. V., and Tikhomirova, I. A. (2013). Role molecular signaling pathways
in changes of red blood cell deformability. Clin. Hemorheol. Microcirc. 53,
45–59. doi: 10.3233/CH-2012-1575
Muzyamba, M. C., Campbell, E. H., and Gibson, J. S. (2006). Effect of intracellular
magnesium and oxygen tension on K+-Cl− cotransport in normal and sickle
human red cells. Cell. Physiol. Biochem. 17, 121–128. doi: 10.1159/000092073
Nans, A., Mohandas, N., and Stokes, D. L. (2011). Native ultrastructure of the
red cell cytoskeleton by cryo-electron tomography. Biophys. J. 101, 2341–2350.
doi: 10.1016/j.bpj.2011.09.050
Nantakomol, D., Palasuwan, A., Chaowanathikhom, M., Soogarun, S., and
Imwong, M. (2012). Red cell and platelet-derived microparticles are increased
in G6PD-deficient subjects. Eur. J. Haematol. 89, 423–429. doi: 10.1111/ejh.
12010
Nathan, D. G., and Gunn, R. B. (1966). Thalassemia: the consequences of
unbalanced hemoglobin synthesis. Am. J. Med. 41, 815–830. doi: 10.1016/0002-
9343(66)90039-8
Nathan, D. G., Oski, F. A., Sidel, V. W., and Diamond, L. K. (1965). Extreme
hemolysis and red-cell distortion in erythrocyte pyruvate kinase deficiency.
N. Engl. J. Med. 272, 118–123. doi: 10.1056/NEJM196501212720302
Nguyen, D. B., Wagner-Britz, L., Maia, S., Steffen, P., Wagner, C., Kaestner, L.,
et al. (2011). Regulation of phosphatidylserine exposure in red blood cells. Cell.
Physiol. Biochem. 28, 847–856. doi: 10.1159/000335798
Odièvre, M.-H., Verger, E., Silva-Pinto, A. C., and Elion, J. (2011).
Pathophysiological insights in sickle cell disease. Indian J. Med. Res. 134,
532–537.
Olivieri, O., De Franceschi, L., Capellini, M. D., Girelli, D., Corrocher, R., and
Brugnara, C. (1994). Oxidative damage and erythrocyte membrane transport
abnormalities in thalassemias. Blood 84, 315–320.
Oonishi, T., Sakashita, K., and Uyesaka, N. (1997). Regulation of red
blood cell filterability by Ca2+ influx and cAMP-mediated signaling
pathways. Am. J. Physiol. 273, C1828–C1834. doi: 10.1152/ajpcell.1997.273.6.
C1828
Oostenbrug, G. S., Mensink, R. P., Hardeman, M. R., De Vries, T., Brouns, F., and
Hornstra, G. (1997). Exercise performance, red blood cell deformability, and
lipid peroxidation: effects of fish oil and vitamin E. J. Appl. Physiol. 83, 746–752.
doi: 10.1152/jappl.1997.83.3.746
Park, Y., Best, C. A., Auth, T., Gov, N. S., Safran, S. A., Popescu, G., et al. (2010).
Metabolic remodeling of the human red blood cell membrane. Proc. Natl. Acad.
Sci. U.S.A. 107, 1289–1294. doi: 10.1073/pnas.0910785107
Parpart, A. K., Lorenz, P. B., Parpart, E. R., Gregg, J. R., and Chase, A. M. (1947).
The osmotic resistance (fragility) of human red cells. J. Clin. Invest. 26, 636–640.
doi: 10.1172/JCI101847
Pattanapanyasat, K., Noulsri, E., Fucharoen, S., Lerdwana, S., Lamchiagdhase, P.,
Siritanaratkul, N., et al. (2004). Flow cytometric quantitation of red blood cell
vesicles in thalassemia. Cytometry B Clin. Cytom. 57, 23–31. doi: 10.1002/cyto.
b.10064
Pauling, L., and Itano, H. A. (1949). Sickle cell anemia a molecular disease. Science
110, 543–548. doi: 10.1126/science.110.2865.543
Perrotta, S., Gallagher, P. G., and Mohandas, N. (2008). Hereditary spherocytosis.
Lancet 372, 1411–1426. doi: 10.1016/S0140-6736(08)61588-3
Peters, L. L., Jindel, H. K., Gwynn, B., Korsgren, C., John, K. M., Lux, S. E., et al.
(1999). Mild spherocytosis and altered red cell ion transport in protein 4. 2-null
mice. J. Clin. Invest. 103, 1527–1537. doi: 10.1172/JCI5766
Picas, L., Rico, F., Deforet, M., and Scheuring, S. (2013). Structural and mechanical
heterogeneity of the erythrocyte membrane reveals hallmarks of membrane
stability. ACS Nano 7, 1054–1063. doi: 10.1021/nn303824j
Picot, J., Ndour, P. A., Lefevre, S. D., El Nemer, W., Tawfik, H., Galimand, J., et al.
(2015). A biomimetic microfluidic chip to study the circulation and mechanical
retention of red blood cells in the spleen. Am. J. Hematol. 90, 339–345.
doi: 10.1002/ajh.23941
Pike, L. J. (2003). Lipid rafts. J. Lipid Res. 44, 655–667. doi: 10.1194/jlr.R200021-
JLR200
Ramdani, G., Naissant, B., Thompson, E., Breil, F., Lorthiois, A., Dupuy, F.,
et al. (2015). cAMP-signalling regulates gametocyte-infected erythrocyte
deformability required for malaria parasite transmission. PLoS Pathog.
11:e1004815. doi: 10.1371/journal.ppat.1004815
Rapetti-Mauss, R., Lacoste, C., Picard, V. V., Guitton, C., Lombard, E.,
Loosveld, M., et al. (2015). A mutation in the Gardos channel is associated
Frontiers in Physiology | www.frontiersin.org 20 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 21
Huisjes et al. Properties of RBC Deformability
with hereditary xerocytosis. Blood 126, 1273–1280. doi: 10.1182/blood-2015-
04-642496
Rees, D. C., Thein, S. L., Osei, A., Drasar, E., Tewari, S., Hannemann, A.,
et al. (2015). The clinical significance of K-Cl cotransport activity in red cells
of patients with HbSC disease. Haematologica 100, 595–600. doi: 10.3324/
haematol.2014.120402
Reid, H. L., Obi, G. O., and Oli, J. M. (1984). Reduced erythrocyte deformability and
hyperfibrinogenemia in Nigerian diabetics with hemoglobin genotype HbAA.
Acta Diabetol. Lat. 21, 105–114. doi: 10.1007/BF02591099
Reinhart, W. H., Kayser, B., Singh, A., Waber, U., Oelz, O., and Bärtsch, P.
(1991). Blood rheology in acute mountain sickness and high-altitude
pulmonary edema. J. Appl. Physiol. 71, 934–938. doi: 10.1152/jappl.1991.71.
3.934
Reliene, R., Mariani, M., Zanella, A., Reinhart, W. H., Ribeiro, M. L., del Giudice,
E. M., et al. (2002). Splenectomy prolongs in vivo survival of erythrocytes
differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis.
Blood 100, 2208–2215.
Rivera, A. (2002). Modulation of Gardos channel activity by cytokines in sickle
erythrocytes. Blood 99, 357–363. doi: 10.1182/blood.V99.1.357
Rivera, A., Rotter, M. A., and Brugnara, C. (1999). Endothelins activate Ca2+-gated
K+ channels via endothelin B receptors in CD-1 mouse erythrocytes. Am. J.
Physiol. 277, C746–C754. doi: 10.1152/ajpcell.1999.277.4.C746
Rother, R. P., Bell, L., Hillmen, P., and Gladwin, M. T. (2005). The clinical
sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a
novel mechanism of human disease. JAMA 293, 1653–1662. doi: 10.1001/jama.
293.13.1653
Sachs, J. R. (2003). “Na+/K+ Pump,” in Red Cell Membrane Transport in Health
and Disease, eds I. Bernhardt, and J. C. Ellory (Berlin: Springer), 111–137.
doi: 10.1007/978-3-662-05181-8_5
Saldanha, C., Silva, A. S., Gonçalves, S., and Martins-Silva, J. (2007). Modulation
of erythrocyte hemorheological properties by band 3 phosphorylation and
dephosphorylation. Clin. Hemorheol. Microcirc. 36, 183–194.
Salomao, M., Zhang, X., Yang, Y., Lee, S., Hartwig, J. H., Chasis, J. A., et al. (2008).
Protein 4.1R-dependent multiprotein complex: New insights into the structural
organization of the red blood cell membrane. Proc. Natl. Acad. Sci. U.S.A. 105,
8026–8031. doi: 10.1073/pnas.0803225105
Salzer, U., and Prohaska, R. (2001). Stomatin, flotillin-1, and flotillin-2 are major
integral proteins of erythrocyte lipid rafts. Blood 97, 1141–1143. doi: 10.1182/
blood.v97.4.1141
Salzer, U., Zhu, R., Luten, M., Isobe, H., Pastushenko, V., Perkmann, T., et al.
(2008). Vesicles generated during storage of red cells are rich in the lipid
raft marker stomatin. Transfusion 48, 451–462. doi: 10.1111/j.1537-2995.2007.
01549.x
Samaja, M., Brenna, L., Allibardi, S., and Cerretelli, P. (1993). Human red blood cell
aging at 5,050-m altitude: a role during adaptation to hypoxia. J. Appl. Physiol.
75, 1696–1701. doi: 10.1152/jappl.1993.75.4.1696
Seider, M. J., and Kim, H. D. (1979). Cow red blood cells. I. Effect of purines,
pyrimidines, and nucleosides in bovine red cell glycolysis. Am. J. Physiol. 236,
C255–C261.
Shalev, O., Mogilner, S., Shinar, E., Rachmilewitz, E. A., and Schrier, S. L. (1984).
Impaired erythrocyte calcium homeostasis in beta-thalassemia. Blood 64,
564–566.
Shimoda, M., Miyashima, K., and Yawata, Y. (1984). Increased calcium uptake
in the red cells of unsplenectomized patients with hereditary spherocytosis:
significant contribution of reticulocytosis. Clin. Chim. Acta 142, 183–192.
doi: 10.1016/0009-8981(84)90378-4
Shin, S., Hou, J. X., Suh, J. S., and Singh, M. (2007). Validation and application
of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte
deformability. Clin. Hemorheol. Microcirc. 37, 319–328.
Shmukler, B. E., Vandorpe, D. H., Rivera, A., Auerbach, M., Brugnara, C., and
Alper, S. L. (2014). Dehydrated stomatocytic anemia due to the heterozygous
mutation R2456H in the mechanosensitive cation channel PIEZO1: a case
report. Blood Cells Mol. Dis. 52, 53–54. doi: 10.1016/j.bcmd.2013.07.015
Sikora, J., Orlov, S. N., Furuya, K., and Grygorczyk, R. (2014). Hemolysis is a
primary ATP-release mechanism in human erythrocytes. Blood 124, 2150–2157.
doi: 10.1182/blood-2014-05-572024
Simpson, R. J., Florida-James, G. D., Whyte, G. P., Middleton, N., Shave, R.,
George, K., et al. (2006). The effects of marathon running on expression of the
complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood
cells. Eur. J. Appl. Physiol. 99, 201–204. doi: 10.1007/s00421-006-0326-2
Smith, J. A. (1995). Exercise, training and red blood cell turnover. Sports Med. 19,
9–31. doi: 10.2165/00007256-199519010-00002
Smith, J. A., Martin, D. T., Telford, R. D., Ballas, S. K., and John, A. (1999).
Greater erythrocyte deformability in world-class endurance athletes Greater
erythrocyte deformability in world-class endurance athletes. Am. J. Physiol. 276,
H2188–H2193.
Spasojevic´, I., Maksimovic´, V., Zakrzewska, J., and Bacic´, G. (2005). Effects of
5-fluorouracil on erythrocytes in relation to its cardiotoxicity: membrane
structure and functioning. J. Chem. Inf. Model. 45, 1680–1685. doi: 10.1021/
ci0501746
Sprague, R. S., Stephenson, A. H., Bowles, E. A., Stumpf, M. S., and Lonigro,
A. J. (2006). Reduced expression of Gi in erythrocytes of humans with type
2 diabetes is associated with impairment of both cAMP generation and ATP
release. Diabetes 55, 3588–3593. doi: 10.2337/db06-0555
Sprague, R. S., Stephenson, A. H., and Ellsworth, M. L. (2007). Red not dead:
signaling in and from erythrocytes. Trends Endocrinol. Metab. 18, 350–355.
doi: 10.1016/j.tem.2007.08.008
Stefanovic, M., Puchulu-Campanella, E., Kodippili, G., and Low, P. S. (2013).
Oxygen regulates the band 3-ankyrin bridge in the human erythrocyte
membrane. Biochem. J. 449, 143–150. doi: 10.1042/BJ20120869
Steffen, P., Jung, A., Nguyen, D. B., Müller, T., Bernhardt, I., Kaestner, L.,
et al. (2011). Stimulation of human red blood cells leads to Ca2+-mediated
intercellular adhesion. Cell Calcium 50, 54–61. doi: 10.1016/j.ceca.2011.
05.002
Stewart, G. W., Amess, J. A., Eber, S. W., Kingswood, C., Lane, P. A., Smith,
B. D., et al. (1996). Thrombo-embolic disease after splenectomy for hereditary
stomatocytosis. Br. J. Haematol. 93, 303–310. doi: 10.1046/j.1365-2141.1996.
4881033.x
Sugie, J., Intaglietta, M., and Sung, L. A. (2018). Water transport and homeostasis
as a major function of erythrocytes. Am. J. Physiol. Circ. Physiol. 314, H1098–
H1107. doi: 10.1152/ajpheart.00263.2017
Szygula, Z. (1990). Erythrocytic system under the influence of physical exercise and
training. Sports Med. 10, 181–197. doi: 10.2165/00007256-199010030-00004
Tang, H.-Y., Ho, H.-Y., Wu, P.-R., Chen, S.-H., Kuypers, F. A., Cheng, M.-L.,
et al. (2015). Inability to maintain GSH pool in G6PD-deficient red cells causes
futile AMPK activation and irreversible metabolic disturbance. Antioxid. Redox
Signal. 22, 744–759. doi: 10.1089/ars.2014.6142
Terra, H. T., Saad, M. J., Carvalho, C. R., Vicentin, D. L., Costa, F. F., and Saad, S. T.
(1998). Increased tyrosine phosphorylation of band 3 in hemoglobinopathies.
Am. J. Hematol. 58, 224–230. doi: 10.1002/(SICI)1096-8652(199807)58:3<224::
AID-AJH11>3.0.CO;2-9
Thali, R. F., Tuerk, R. D., Scholz, R., Yoho-Auchli, Y., Brunisholz, R. A., and
Neumann, D. (2010). Novel candidate substrates of AMP-activated protein
kinase identified in red blood cell lysates. Biochem. Biophys. Res. Commun. 398,
296–301. doi: 10.1016/j.bbrc.2010.06.084
Thomas, S. L. Y., Bouyer, G., Cueff, A., Egée, S., Glogowska, E., and Ollivaux, C.
(2011). Ion channels in human red blood cell membrane: actors or relics? Blood
Cells Mol. Dis. 46, 261–265. doi: 10.1016/j.bcmd.2011.02.007
Tiffert, T., Bookchin, R. M., and Lew, V. L. (2003). “Calcium homeostasis in normal
and abnormal human red cells,” in Red Cell Membrane Transport in Health
and Disease, eds I. Bernhardt, and J. C. Ellory (Berlin: Springer), 373–405.
doi: 10.1007/978-3-662-05181-8_15
Tomaiuolo, G. (2014). Biomechanical properties of red blood cells in health
and disease towards microfluidics. Biomicrofluidics 8:051501. doi: 10.1063/1.
4895755
Tomoda, A., Noble, N. A., Lachant, N. A., and Tanaka, K. R. (1982). Hemolytic
anemia in hereditary pyrimidine 5′-nucleotidase deficiency: nucleotide
inhibition of G6PD and the pentose phosphate shunt. Blood 60, 1212–1218.
Tuvia, S., Levin, S., Bitler, A., and Korenstein, R. (1998). Mechanical fluctuations
of the membrane-skeleton are dependent on F-actin ATPase in human
erythrocytes. J. Cell Biol. 141, 1551–1561. doi: 10.1083/jcb.141.7.1551
Tuvia, S., Moses, A., Gulayev, N., Levin, S., and Korenstein, R. (1999). Beta-
adrenergic agonists regulate cell membrane fluctuations of human erythrocytes.
J. Physiol. 516(Pt 3), 781–792. doi: 10.1111/j.1469-7793.1999.0781u.x
Vader, P., Fens, M. H., Sachini, N., van Oirschot, B. A., Andringa, G., Egberts, A. C.,
et al. (2013). Taxol( R©)-induced phosphatidylserine exposure and microvesicle
Frontiers in Physiology | www.frontiersin.org 21 June 2018 | Volume 9 | Article 656
fphys-09-00656 June 1, 2018 Time: 12:28 # 22
Huisjes et al. Properties of RBC Deformability
formation in red blood cells is mediated by its vehicle Cremophor( R©) EL.
Nanomedicine 8, 1127–1135. doi: 10.2217/nnm.12.163
van Wijk, R., and van Solinge, W. W. (2005). The energy-less red blood cell is
lost: erythrocyte enzyme abnormalities of glycolysis. Blood 106, 4034–4042.
doi: 10.1182/blood-2005-04-1622
Vives Corrons, J. L., and Besson, I. (2001). Red cell membrane Na+ transport
systems in hereditary spherocytosis: relevance to understanding the increased
Na+ permeability. Ann. Hematol. 80, 535–539. doi: 10.1007/s002770100342
Vives L Corrons, J. L. (2000). Chronic non-spherocytic haemolytic anaemia due to
congenital pyrimidine 5’ nucleotidase deficiency: 25 years later. Best Pract. Res.
Clin. Haematol. 13, 103–118. doi: 10.1053/beha.1999.0060
Wagner-Britz, L., Wang, J., Kaestner, L., and Bernhardt, I. (2013). Protein kinase
Ca and P-Type Ca2+ Channel CaV2.1 in red blood cell calcium signalling. Cell.
Physiol. Biochem. 31, 883–891. doi: 10.1159/000350106
Wang, J., Wagner-Britz, L., Bogdanova, A., Ruppenthal, S., Wiesen, K.,
Kaiser, E., et al. (2013). Morphologically homogeneous red blood cells present
a heterogeneous response to hormonal stimulation. PLoS One 8:e67697.
doi: 10.1371/journal.pone.0067697
Wang, S., Dale, G. L., Song, P., Viollet, B., and Zou, M.-H. (2010). AMPKalpha1
deletion shortens erythrocyte life span in mice: role of oxidative stress. J. Biol.
Chem. 285, 19976–19985. doi: 10.1074/jbc.M110.102467
Wang, W., Yang, X., López de Silanes, I., Carling, D., and Gorospe, M. (2003).
Increased AMP:ATP ratio and AMP-activated protein kinase activity during
cellular senescence linked to reduced HuR function. J. Biol. Chem. 278,
27016–27023. doi: 10.1074/jbc.M300318200
Ware, R. E., de Montalembert, M., Tshilolo, L., and Abboud, M. R. (2017). Sickle
cell disease. Lancet 390, 311–323. doi: 10.1016/S0140-6736(17)30193-9
Waugh, R. E., Narla, M., Jackson, C. W., Mueller, T. J., Suzuki, T., and Dale, G. L.
(1992). Rheologic properties of senescent erythrocytes: loss of surface area and
volume with red blood cell age. Blood 79, 1351–1358.
Weed, R. I., LaCelle, P. L., and Merrill, E. W. (1969). Metabolic dependence of red
cell deformability. J. Clin. Invest. 48, 795–809. doi: 10.1172/JCI106038
Werre, J. M., Willekens, F. L., Bosch, F. H., de Haans, L. D., van der Vegt, S. G.,
van den Bos, A. G., et al. (2004). The red cell revisited–matters of life and death.
Cell. Mol. Biol. 50, 139–145.
Wieth, J. O. (1979). Bicarbonate exchange through the human red cell membrane
determined with [14C] bicarbonate. J. Physiol. 294, 521–539. doi: 10.1113/
jphysiol.1979.sp012944
Willekens, F. L., Werre, J. M., Groenen-Döpp, Y. A., Roerdinkholder-
Stoelwinder, B., de Pauw, B., and Bosman, G. J. (2008). Erythrocyte vesiculation:
a self-protective mechanism? Br. J. Haematol. 141, 549–556. doi: 10.1111/j.
1365-2141.2008.07055.x
Wolfersberger, M. G. (1994). Uniporters, symporters and antiporters. J. Exp. Biol.
196, 5–6.
Yang, B., Ma, T., and Verkman, A. S. (2001). Erythrocyte water permeability
and renal function in double knock out mice lacking aquaporin-1
and aquaporin-3. J. Biol. Chem. 276, 624–628. doi: 10.1074/jbc.M00866
4200
Yeow, N., Tabor, R. F., and Garnier, G. (2017). Atomic force microscopy: from red
blood cells to immunohaematology. Adv. Colloid Interface Sci. 249, 149–162.
doi: 10.1016/j.cis.2017.05.011
Zanella, A., and Bianchi, P. (2000). Red cell pyruvate kinase deficiency: from
genetics to clinical manifestations. Best Pract. Res. Clin. Haematol. 13, 57–81.
doi: 10.1053/beha.1999.0057
Zanella, A., Bianchi, P., Fermo, E., and Valentini, G. (2006). Hereditary
pyrimidine 5 ’-nucleotidase deficiency: from genetics to clinical
manifestations. Br. J. Haematol. 133, 113–123. doi: 10.1111/j.1365-2141.2006.
05992.x
Zanella, A., Fermo, E., Bianchi, P., Chiarelli, L. R., and Valentini, G. (2007).
Pyruvate kinase deficiency: the genotype-phenotype association. Blood Rev. 21,
217–231. doi: 10.1016/j.blre.2007.01.001
Zarychanski, R., Schulz, V. P., Houston, B. L., Maksimova, Y., Houston, D. S.,
Smith, B., et al. (2012). Mutations in the mechanotransduction protein PIEZO1
are associated with hereditary xerocytosis. Blood 120, 1908–1915. doi: 10.1182/
blood-2012-04-422253
Zeuthen, T., and Macaulay, N. (2012). Transport of water against its concentration
gradient: fact or fiction? WIREs Membr. Transp. Signal. 1, 373–381.
doi: 10.1002/wmts.54
Zhong, R., Liu, H., Wang, H., Li, X., He, Z., Gangla, M., et al. (2015). Adaption
to high altitude: an evaluation of the storage quality of suspended red blood
cells prepared from the whole blood of Tibetan plateau migrants. PLoS One
10:e0144201. doi: 10.1371/journal.pone.0144201
Zipser, Y., Piade, A., Barbul, A., Korenstein, R., and Kosower, N. S. (2002).
Ca2+ promotes erythrocyte band 3 tyrosine phosphorylation via dissociation
of phosphotyrosine phosphatase from band 3. Biochem. J. 368, 137–144.
doi: 10.1042/BJ20020359
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Huisjes, Bogdanova, van Solinge, Schiffelers, Kaestner and van
Wijk. This is an open-access article distributed under the terms of the Creative
Commons Attribution License (CC BY). The use, distribution or reproduction in
other forums is permitted, provided the original author(s) and the copyright owner
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 22 June 2018 | Volume 9 | Article 656
